LV14476B - Sythesis of biologically active 4-acylamino-4,5,6,7-tetrahydroindazoles - Google Patents

Sythesis of biologically active 4-acylamino-4,5,6,7-tetrahydroindazoles Download PDF

Info

Publication number
LV14476B
LV14476B LVP-11-167A LV110167A LV14476B LV 14476 B LV14476 B LV 14476B LV 110167 A LV110167 A LV 110167A LV 14476 B LV14476 B LV 14476B
Authority
LV
Latvia
Prior art keywords
acid
mmol
conc
equiv
limited
Prior art date
Application number
LVP-11-167A
Other languages
Latvian (lv)
Other versions
LV14476A (en
Inventor
Māris TURKS
Inta Strakova
Kirils GOROVOJS
Yury A. Piven
Tatsiana S. Khlebnikava
Fiodor A. Lakhvich
Marina B. GOLUBEVA
Inha A. Kantrouskaya
Original Assignee
Rīgas Tehniskā Universitāte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rīgas Tehniskā Universitāte filed Critical Rīgas Tehniskā Universitāte
Priority to LVP-11-167A priority Critical patent/LV14476B/en
Publication of LV14476A publication Critical patent/LV14476A/en
Publication of LV14476B publication Critical patent/LV14476B/en

Links

Landscapes

  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a novel method of synthesis of 4-acylamino-4,5,6,7-tetrahydroindazoles with general formula (I). The method consists of Ritter reaction between 4-hydroxy-4,5,6,7-tetrahydroindazoles or 6,7-dihydroindazoles and various nitriles in acidic medium which generates the corresponding tetrahydroindazolyl cation. Compounds (I) possess analgesic activity.

Description

Izgudrojuma aprakstsDescription of the Invention

Izgudrojums attiecas uz medicīnas ķīmijas nozari - l-aril-3,6,6-trimetil-, l-hetaril-3,6,6-trimetilun l-aril-6,6-dimetil-4-acilamino-4,5,6,7-tetrahidroindazolu (2) sintēzi un to analgētisko īpašību atklāšanu.The invention relates to the field of medical chemistry - 1-aryl-3,6,6-trimethyl-, 1-hetaryl-3,6,6-trimethyl and l-aryl-6,6-dimethyl-4-acylamino-4,5,6 , 7-tetrahydroindazole (2) and their analgesic properties.

Vairāki tetrahidroindazolu atvasinājumi ir farmakoloģiski pielietojami savienojumi ar pretiekaisuma [Bhatia, R. K.; Raju, P. B.; Jain, U. K.; Kumar, P. P.; Satyavathi, K. Res. J. Pharm. Biol. Chem. Sci. 2011, 2, 118-129; Nagakura, M.; Ota, T.; Shimidzu, N.; Kawamura, K.; Eto, Y.; Wada, Y. J. Med. Chem. 1979, 22, 48-52], analgezējošu [Badawey, E.A.M.; El-Ashmawey, I. M. Eur. J. Med. Chem. 1998, 33, 349-361; El-Hawash, S. Α. M.; Badawey, Ε. Α. M.; El-Ashmawey, I. M. Eur. J. Med. Chem. 2006, 41, 155-165], pretaudzēju [Connolly, P. J.; Wetter, S. K.; Beers, Κ. N.; Hamel, S. C.; HaynesJohnson, D.; Kiddoe, M.; Kraft, P.; Tsann Lai, M.; Campen, C.; Palmer, S.; Phillips, A. Bioorg. Med. Chem. Lett. 1997, 7,2551-2556], antibakteriālu [Lorand, T.; Kocsis, B.; Emody, L.; Sohar, P. Eur. J. Med. Chem. 1999, 34, 1009-1018], pretvīrusu un daudzām citām īpašībām [Cerecetto, H.; Gerpe, A.; Gonzalez, M.; Aran, V. J.; de Ocariz, C. O. Mini-Rev. Med. Chem. 2005,5, 869-878.].Several derivatives of tetrahydroindazoles are pharmacologically useful compounds with anti-inflammatory activity [Bhatia, R. K .; Raju, P. B.; Jain, U.K .; Kumar, P. P.; Satyavathi, K. Res. J. Pharm. Biol. Chem. Sci. 2011, 2, 118-129; Nagakura, M .; Ota, T .; Shimidzu, N .; Kawamura, K .; Eto, Y .; Wada, Y. J. Med. Chem. 1979, 22, 48-52], analgesic [Badawey, E.A.M .; El-Ashmawey, I. M. Eur. J. Med. Chem. 1998, 33, 349-361; El-Hawash, S. Α. M .; Badawey, Ε. Α. M .; El-Ashmawey, I. M. Eur. J. Med. Chem. 2006, 41, 155-165], anti-tumor [Connolly, P.J.; Wetter, S. K.; Beers, Κ. N .; Hamel, S. C .; HaynesJohnson, D.; Kiddoe, M .; Kraft, P .; Tsann Lai, M .; Campen, C .; Palmer, S.; Phillips, A. Bioorg. Med. Chem. Lett. 1997, 7,2551-2556], antibacterial [Lorand, T .; Kochi, B .; Emody, L .; Sohar, P. Eur. J. Med. Chem. 1999, 34, 1009-1018], antiviral and many other properties [Cerecetto, H .; Gerpe, A .; Gonzalez, M .; Aran, V. J.; de Ocariz, C. O. Mini-Rev. Med. Chem. 2005.5, 869-878.].

4-Amino-tetrahidroindazoli sintezēti ar labiem iznākumiem 1-piridilatvasinājumu sērijā, reducējot attiecīgos 4-oksīmus, bet pārējiem atvasinājumiem šī pieeja nav izrādījusies veiksmīga. Iegūtajiem savienojumiem patentēta to pretvēža aktivitāte un lietojums Alcheimera slimības ārstēšanā [Pevarello, P.; Villa, M.; Varasi, M.; Isacchi, A. US Pat 6716856 (Bl), 06.04.2004],4-Amino-tetrahydroindazoles have been synthesized with good yields in the 1-pyridyl derivatives series by reduction of the corresponding 4-oximes, but this approach has not been successful for the other derivatives. The resulting compounds are patented for their anti-cancer activity and use in the treatment of Alzheimer's disease [Pevarello, P .; Villa, M .; Varasi, M .; Isacchi, A. US Pat. 6716856 (B1), 06.04.2004]

Ir zināma Rittera reakcija [Bishop, R.; In Comp.Org.Synth.; Trost, B.M., Fleming, I.; Egs.; Pergamon Press: New York, 1992; Vol. 6, 261.; Krimen, L.I.; Cota, D.I. Org. React., 1969, 17, 213.; Jirgensons, A.; Kauss, V.; Kalvinsh, I; Gold, M.R., Synthesis 2000, 1709.] acilamīnu sintēzei no hidroksisavienojumiem vai olefīniem un nitriliem koncentrētas sērskābes kā katalizatora klātienē. THI rindā šāda reakcija nav zināma.Ritter's reaction is known [Bishop, R .; In Comp.Org.Synth .; Trost, B.M., Fleming, I.; Eg .; Pergamon Press: New York, 1992; Vol. 6, 261; Krimen, L.I .; Cota, D.I. Org. React., 17, 213 (1969); Jirgensons, A .; Bowl, V.; Kalvinsh, I; Gold, M.R., Synthesis 2000, 1709.] for the synthesis of acylamines from hydroxy compounds or olefins and nitriles in the presence of concentrated sulfuric acid as a catalyst. In the THI series, such a reaction is unknown.

Piedāvātais izgudrojums attiecas uz jaunas metodes izstrādi 1-aril- un l-heteril-4-acilamino4,5,6,7-tetrahidroindazolu iegūšanai un to pārvēršanu 4-amino-4,5,6,7-tetrahidroindazolos. Izgudrojuma mērķis ir sasniegts, realizējot alkil-, aril- un hetarilnitrilu (R3CN) reakcijas ar 4-hidroksi-4,5,6,7-THI (lac) vienā stadijā skābā vidē 60 - 70 °C temperatūrā, iegūstot mērķsavienojumus 2 ar augstu iznākumu. Kā reakcijas vide lietotas dažādas skābes: ledus etiķskābe, trifluoretiķskābe, konc. sērskābe, konc. fosforskābe, polifosforskābe, konc. perhlorskābe, p-toluolsulfoskābe, kamparsulfoskābe un to maisījumi.The present invention relates to the development of a new process for the preparation of 1-aryl- and 1-heteryl-4-acylamino-4,5,6,7-tetrahydroindazoles and their conversion to 4-amino-4,5,6,7-tetrahydroindazoles. The object of the invention is achieved by reacting alkyl, aryl and hetaryl nitrile (R 3 CN) with 4-hydroxy-4,5,6,7-THI (lac) in one step in an acidic medium at 60-70 ° C to obtain the target compounds 2. with high yield. The reaction medium used was various acids: glacial acetic acid, trifluoroacetic acid, conc. sulfuric acid, conc. phosphoric acid, polyphosphoric acid, conc. perchloric acid, p-toluenesulfonic acid, camphorsulfonic acid and mixtures thereof.

la, 3a: R1=Ph; R2=H lb, 3b: R1=Ph; R2=Me skābela, 3a: R 1 = Ph; R 2 = H 1b, 3b: R 1 = Ph; R 2 = Me acid

Alternatīvi iespējama 4-hidroksi-4,5,6,7-THI (la-c) parveršana 6,7-dihidroindazola atvasinājumos 3, kuri tālāk skābā vidē reaģē ar nitriliem, dodot mērķa amīdus 2.Alternatively, 4-hydroxy-4,5,6,7-THI (la-c) can be converted into 6,7-dihydroindazole derivatives 3, which are further reacted with nitriles in the acidic medium to give the target amides 2.

Noteikts, ka iegūtā vielu grupa ar vispārējo formulu 2 ir praktiski netoksiska (LD50 > 2000 mg/kg; orāli pelēm). Reprezentatīviem acilatvasinājumiem 2a [A-(6,6-dimetil-l-fenil-4,5,6,7-tetraliīdro-l/iindazol-4-il)-3-metoksi-benzamīdam] un 2b [A-(3,6,6-trimetil-l-fenil-4,5,6,7-tetrahidro-177-indazol-4-il)acetamīdam] tika noteikta to analgētiskā aktivitāte etiķskābes ierosinātā abdominālā muskuļu spazmu modelī uz pelēm. Šie savienojumi samazina kuņģa spazmas par attiecīgi 18% un 13%.The resulting group of substances of general formula 2 was found to be substantially non-toxic (LD50> 2000 mg / kg; oral in mice). Representative acyl derivatives 2a [A- (6,6-dimethyl-1-phenyl-4,5,6,7-tetralidro-1 H -indazol-4-yl) -3-methoxy-benzamide] and 2b [A- (3, 6,6-trimethyl-1-phenyl-4,5,6,7-tetrahydro-177-indazol-4-yl) -acetamide] was determined for their analgesic activity in an acetic acid-induced abdominal muscle spasm model in mice. These compounds reduce stomach cramps by 18% and 13%, respectively.

Piemērs 1.Example 1.

A-(^5^Dimetil-l-feniM,5,6,7-tetrahidro-l//-indazol-4-il)-acetaniīds l-Fenil-4-hidroksi-6,6-dimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina acetonitrilu (0,4 mL, 8 mmol, 2 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N - (N, N-dimethyl-1-phenyl, 5,6,7-tetrahydro-1 H -indazol-4-yl) -acetanide 1-Phenyl-4-hydroxy-6,6-dimethyl-4,5 To a solution of 6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (1.1 mL, 20 mmol, 5 equiv) with magnetic stirring, then added dropwise acetonitrile (0.4 mL, 8 mmol, 2 equiv.). Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1,10 g, (95%).Yield: 1.10 g (95%).

Balta cieta viela, Rf = 0,06 (T/E = 1/1)White solid, Rf = 0.06 (T / E = 1/1)

k.p. 198 °C (EtOH/H2O 1/1)bp 198 ° C (EtOH / H 2 O 1/1)

IS (KBr) : 3265, 3068, 2963, 2905, 1645, 1634, 1601, 1554, 1510, 1455, 1396, 1383, 1371, 1293, 1276, 1178,1141,1130,1066,966.IS (KBr): 3265, 3068, 2963, 2905, 1645, 1634, 1601, 1554, 1510, 1455, 1396, 1383, 1371, 1293, 1276, 1178, 1141, 1130, 1066, 966.

‘H-KMR (300 MHz, CDClļ) δ (ppm): 7.60 (s, 1H, H-C(3)), 7.50-7.44 (m, 4H, Ph-N(l)), 7.39-7.31 (m,1 H-NMR (300 MHz, CDCl 3) δ (ppm): 7.60 (s, 1H, H-C (3)), 7.50-7.44 (m, 4H, Ph-N (1)), 7.39-7.31 (m,

IH, Ph-N(l)), 5.73 (d, 1H, 3/ = 8.3 Hz, H-N-C(4)), 5.14, (ddd, 1H, 3J = 9.8 Hz, 3J = 8.3 Hz, 3J= 7.2 Hz, H-C(4)), 2.60 (d, 1H, 2J = 16.0 Hz, Ha-C(7)), 2.43 (d, 1H, 2J = 16.0 Hz, Hb-C(7)), 2.03 (s, 3H, H-C(2’)), 2.01 (ddd, 1H, 2J= 13.2 Hz, 3J= 7.2 Hz, V= 1.1 Hz, Hb-C(5)), 1.35 (dd, 1H, 2J = 13.0 Hz, 3J= 9.8 Hz, Ha-C(5)), 1.10 (s, 3H, H3C-C(5)), 0.96 (s, 3H, H3C-C(5)).1H, Ph-N (1)), 5.73 (d, 1H, 3 / = 8.3 Hz, HNC (4)), 5.14, (ddd, 1H, 3 J = 9.8 Hz, 3 J = 8.3 Hz, 3 J = 7.2 Hz, HC (4)), 2.60 (d, 1H, 2 J = 16.0 Hz, Ha-C (7)), 2.43 (d, 1H, 2 J = 16.0 Hz, Hb-C (7)), 2.03 (s, 3H, HC (2 ')), 2.01 (ddd, 1H, 2 J = 13.2 Hz, 3 J = 7.2 Hz, V = 1.1 Hz, Hb-C (5)), 1.35 (dd, 1H, 2 J = 13.0 Hz, 3 J = 9.8 Hz, Ha-C (5)), 1.10 (s, 3H, H 3 CC (5)), 0.96 (s, 3H, H 3 CC (5)).

13C-KMR (75 MHz, CDC13) δ (ppm): 169.7, 139.5, 139.1, 137.9, 129.1, 127.2, 123.3, 118.1, 43.5, 41.8, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 169.7, 139.5, 139.1, 137.9, 129.1, 127.2, 123.3, 118.1, 43.5, 41.8,

36.9, 32.6, 30.8,25.3,23.5.36.9, 32.6, 30.8,25.3,23.5.

Elementāranalīze: aprēķināts C1SH23N3O (279.18): C 72.06, H 7.47, N 14.83; atrasts C 75.85, H 6.96, NElemental Analysis: Calculated for C 18 H 23 N 3 O (279.18): C 72.06, H 7.47, N 14.83; found C 75.85, H 6.96, N

II. 54.II. 54.

Piemērs 2.Example 2.

7V-(6,6-DimetiI-l-feniM,5,6,7-tetrahidro-lZZ-indazol-4-il)-benzaniīds l-Fenil-4-hidroksi-6,6-dimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv ), tad piepilina benzonitrilu (1,2 mL, 12 mmol, 3 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:2).N- (6,6-Dimethyl-1-phenyl, 5,6,7-tetrahydro-2Z-indazol-4-yl) -benzamide 1-Phenyl-4-hydroxy-6,6-dimethyl-4,5,6 To a solution of 7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added magnetic sulfuric acid (1.1 mL, 20 mmol, 5 equiv) with stirring, then benzonitrile was added ( 1.2 mL, 12 mmol, 3 equiv). Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 2).

Iznākums: 1,00 g, (73%).Yield: 1.00 g (73%).

Balta cieta viela, Rf = 0.60 (T/E = 2/1)White solid, Rf = 0.60 (T / E = 2/1)

k.p. 160 °C (EtOH/H2O 1/2)bp 160 ° C (EtOH / H 2 O 1/2)

IS (KBr): 3271,2955,1627, 1600, 1578, 1534, 1505,1490, 1401,1294,1182,1149,1067,968.IS (KBr): 3271, 2955, 1627, 1600, 1578, 1534, 1505, 1490, 1401, 1294, 1182, 1149, 1067, 968.

*H-KMR (300 MHz, CDC13) δ (ppm): 7.81 (dd, 2H, 3J= 7.7 Hz, 4J = 0.9 Hz, Ph-C(l’)), 7.66 (s, 1H, HC(3)), 7.54-7.41 (m, 7H, Ph-N(l), Ph-C(l’)), 7.40-7.32 (m, 1H, Ph-N(l)), 6.34 (d, 1H, 3J= 8.5 Hz, H-NC(4)), 5.37 (ddd, 1H, 3J= 9.4 Hz, 3J= 8.5 Hz, 3J= 5.8 Hz, H-C(4)), 2.62 (dd, 1H, 2J = 16.2 Hz, 4J= 1.1 Hz, H*-C(7)), 2.48 (d, 1H, 2J = 16.0 Hz, Hb-C(7)), 2.12 (ddd, 1H, 2J= 12.8 Hz, 3J= 5.8 Hz, 4J= 1.1 Hz, Ha-C(5)), 1.49 (dd, 1H, 2J = 12.8 Hz, 3J= 9.4 Hz, Hb-C(5)), 1.14 (s, 3H, H3C-C(5)), 1.02 (s, 3H, H3CC(5)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.81 (dd, 2H, 3 J = 7.7 Hz, 4 J = 0.9 Hz, Ph-C (1 ')), 7.66 (s, 1H, HC) (3)), 7.54-7.41 (m, 7H, Ph-N (1), Ph-C (1 ')), 7.40-7.32 (m, 1H, Ph-N (1)), 6.34 (d, 1H , 3 J = 8.5 Hz, H-NC (4)), 5.37 (ddd, 1H, 3 J = 9.4 Hz, 3 J = 8.5 Hz, 3 J = 5.8 Hz, HC (4)), 2.62 (dd, 1H , 2 J = 16.2 Hz, 4 J = 1.1 Hz, H * -C (7)), 2.48 (d, 1H, 2 J = 16.0 Hz, Hb-C (7)), 2.12 (ddd, 1H, 2 J) = 12.8 Hz, 3 J = 5.8 Hz, 4 J = 1.1 Hz, Ha-C (5)), 1.49 (dd, 1H, 2 J = 12.8 Hz, 3 J = 9.4 Hz, H b -C (5)) , 1.14 (s, 3H, H 3 CC (5)), 1.02 (s, 3H, H 3 CC (5)).

13C-KMR (75 MHz, CDC13) δ (ppm): 167.1, 139.7, 139.2, 138.2, 134.5, 131.6, 129.2, 128.6, 127.2, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 167.1, 139.7, 139.2, 138.2, 134.5, 131.6, 129.2, 128.6, 127.2,

126.9, 123.4,118.0,43.6, 42.4, 37.0, 32.8, 30.8, 25.6.126.9, 123.4,118.0,43.6, 42.4, 37.0, 32.8, 30.8, 25.6.

Elementāranalīze: aprēķināts C22H23N3O (345.18): C 76.49, H 6.71, N 12.16; atrasts C 76.36, H 6.81, N 11.93.Elemental Analysis: Calculated for C 22 H 23 N 3 O (345.18): C 76.49, H 6.71, N 12.16; found C 76.36, H 6.81, N 11.93.

Piemērs 3.Example 3.

7V-(6,6-Dimetil-l-fenil-4,5,6,7-tetrahidro-l/Z-indazoI-4-iI)-trihloracetamīds l-Fenil-4-hidroksi-6,6-dimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (2,2 mL, 40 mmol, 10 ekv.), tad piepilina trihloracetonitrilu (8,0 mL, 80 mmol, 20 ekv.). Aiztaisītā kolbā 20 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:0,9).N- (6,6-Dimethyl-1-phenyl-4,5,6,7-tetrahydro-1 H -indazol-4-yl) -trichloroacetamide 1-Phenyl-4-hydroxy-6,6-dimethyl-4 To a solution of 5,6,7-tetrahydro-indazole (0.96 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (2.2 mL, 40 mmol, 10 equiv) with magnetic stirring. then add trichloroacetonitrile (8.0 mL, 80 mmol, 20 equiv). Continue stirring in a sealed flask at 60 ° C for 20 hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 0.9).

Iznākums: 0,77 g, (50%).Yield: 0.77 g (50%).

Balta cieta viela, Rf = 0,69 (T/E =1/1)White solid, Rf = 0.69 (T / E = 1/1)

k.p. 145 °C (EtOH/H2O 1/0,9)bp 145 ° C (EtOH / H 2 O 1 / 0.9)

IS (KBr): 3034, 2958, 2934, 1601,1561, 1507,1424,1387, 896.IS (KBr): 3034, 2958, 2934, 1601, 1561, 1507, 1424, 1387, 896.

'H-KMR (300 MHz, CDC13) δ (ppm): 7.64 (s, 1H, H-C(3)), 7.51-7.45 (m, 4H, Ph-N(l)), 7.41-7.34 (m, 1H, Ph-N(l)), 6.79 (d, 1H, \ΐ=Ί.Ί Hz, H-N-C(4)), 5.13 (ddd, 1H, 3J = 9.2 Hz, 3J= 7.7 Hz, 3/= 6.1 Hz, H-C(4)), 2.62 (d, 1H, 2/= 16.4 Hz, Ha-C(7)), 2.49 (d, 1H, 2J= 16.4 Hz, Hb-C(7)), 2.08 (ddd, 1H, 2J= 13.1 Hz, 3J = 6.1 Hz, 4./ = 1.0Hz, H«-C(5)), 1.53 (ddd, 1H, 2J= 13.0 Hz,3J= 9.2 Hz, Hb-C(5)), 1.15 (s, 3H, H3C-C(6)), 1.02 (s, 3H, H3C-C(6)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.64 (s, 1H, HC (3)), 7.51-7.45 (m, 4H, Ph-N (1)), 7.41-7.34 (m, 1H, Ph-N (l)), 6.79 (d, 1H, ΐ = Ί.Ί Hz, HNC (4)), 5.13 (ddd, 1H, 3 J = 9.2 Hz, 3 J = 7.7 Hz, 3 / = 6.1 Hz, HC (4)), 2.62 (d, 1H, 2 / = 16.4 Hz, Ha-C (7)), 2.49 (d, 1H, 2 J = 16.4 Hz, Hb-C (7)), 2.08 (ddd, 1H, 2 J = 13.1 Hz, 3 J = 6.1 Hz, 4 ./ = 1.0 Hz, H 1 -C (5)), 1.53 (ddd, 1H, 2 J = 13.0 Hz, 3 J = 9.2 Hz, H b -C (5)), 1.15 (s, 3H, H 3 CC (6)), 1.02 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDC13) δ (ppm): 161.6, 139.7, 139.1, 137.5, 129.3, 127.7, 123.6, 116.4, 92.6, 44.2, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 161.6, 139.7, 139.1, 137.5, 129.3, 127.7, 123.6, 116.4, 92.6, 44.2,

42.6, 36.7, 32.6,30.4,25.7.42.6, 36.7, 32.6,30.4,25.7.

Elementāranalīze: aprēķināts Ci7HisCl3N3O (385.05): C 52.80, H 4.69, N 10.87; atrasts C 52.80, H 4.56, N 10.79.Elemental Analysis: Calculated for C 17 H 15 Cl 3 N 3 O (385.05): C 52.80, H 4.69, N 10.87; Found: C 52.80, H 4.56, N 10.79.

Piemērs 4.Example 4.

7V-(6,6-Dimetil-l-fenil-4,5,6,7-tetrahidro-lH-indazol-4-il)-4-nitro-benzamīds l-Fenil-4-hidroksi-6,6-dimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina p-nitrobenzonitrilu (0,89 g, 6 mmol, 1,5 ekv.). Aiztaisītā kolbā 9 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (6,6-Dimethyl-1-phenyl-4,5,6,7-tetrahydro-1H-indazol-4-yl) -4-nitrobenzamide 1-Phenyl-4-hydroxy-6,6-dimethyl To a solution of -4,5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (1.1 mL, 20 mmol, 5 equiv) with magnetic stirrer ), then p-nitrobenzonitrile (0.89 g, 6 mmol, 1.5 eq) was added. Continue stirring in a sealed flask for 9 hours at 60 ° C. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1.05 g, (65%).Yield: 1.05 g, (65%).

Balta cieta viela, Rf = 0,55 (T/E = 1/1)White solid, Rf = 0.55 (T / E = 1/1)

k.p. 168 °C (EtOH/H2O 1/1)bp 168 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3392,2960,2920,2864,1645, 1599,1527,1504,1486,1476,1454,1402,1349,1191,975. ’ll-KMR (300 MHz, CDC13) δ (ppm): 8.30 (d, 2H, 3,/= 8.7 Hz, p-NOj-C^-Cil’)), 7.98 (d, 2H, 3J= 8.7 Hz, p-NO2-C6H4-C(l’)), 7.64 (s, 1H, H-C(3)), 7.49-7.45 (m, 4H, Ph-N(l)), 7.40-7.34 (m, 1H, Ph-N(l)), 6.50 (d, 1H, V= 8.1 Hz, H-N-C(4)), 5.36 (ddd, 1H, 3J= 9.6 Hz, 3J= 8.1 Hz, 3J= 5.7 Hz, H-C(4)), 2.62 (d, 1H, 2J= 16.4 Hz, Ha-C(7)), 2.49 (d, 1H, 2J= 16.4 Hz, Hb-C(7)), 2.13 (dd, 1H, 2J= 12.8 Hz, 3J= 5.7 Hz, Ha-C(5)), 1.47 (dd, 1H, 2J= 13.0 Hz, 3J= 9.6 Hz, H<r=C(5)), 1.14 (s, 3H, H3C-C(6)), 1.02 (s, 3H, H3CC(6)).IS (KBr): 3392, 2960, 2920, 2864, 1645, 1599, 1527, 1504, 1486, 1476, 1454, 1402, 1349, 1191, 975. 11 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 8.30 (d, 2H, 3 , δ = 8.7 Hz, p-NOj-C ^-Cil '), 7.98 (d, 2H, 3 J = 8.7 Hz, p-NO2-C6H4-C (1 '), 7.64 (s, 1H, HC (3)), 7.49-7.45 (m, 4H, Ph-N (1)), 7.40-7.34 (m, 1H, Ph-N (l)), 6.50 (d, 1H, V = 8.1 Hz, HNC (4)), 5.36 (ddd, 1H, 3 J = 9.6 Hz, 3 J = 8.1 Hz, 3 J = 5.7 Hz , HC (4)), 2.62 (d, 1H, 2 J = 16.4 Hz, Ha-C (7)), 2.49 (d, 1H, 2 J = 16.4 Hz, Hb-C (7)), 2.13 (dd) , 1H, 2 J = 12.8 Hz, 3 J = 5.7 Hz, Ha-C (5)), 1.47 (dd, 1H, 2 J = 13.0 Hz, 3 J = 9.6 Hz, H <r = C (5)) , 1.14 (s, 3H, H 3 C -C (6)), 1.02 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDC13) δ (ppm): 165.0, 149.6, 140.0, 139.4, 139.3, 138.0, 129.3, 128.2, 127.4, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 165.0, 149.6, 140.0, 139.4, 139.3, 138.0, 129.3, 128.2, 127.4,

123.8,123.2, 117.4,43.3,42.8, 37.0, 32.8, 30.8,25.4.123.8,123.2, 117.4,43.3,42.8, 37.0, 32.8, 30.8,25.4.

Elementāranalīze: aprēķināts C23H24N4O3 (404.18): C 67.68, H 5.68, N 14.35; atrasts C 67.80, H 4.56, N 10.79.Elemental Analysis: Calculated for C 23 H 24 N 4 O 3 (404.18): C 67.68, H 5.68, N 14.35; Found: C 67.80, H 4.56, N 10.79.

Piemērs 5.Example 5.

/V-(6,6-DimetiI-l-fenil-4,5,6,7-tetrahidro-l//-indazol-4-il)-3-metoksi-benzamīds l-Fenil-4-hidroksi-6,6-dimetil-4,5,6,7-tetrabidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (0,9 mL, 16 mmol, 4 ekv.), tad piepilina m-metoksibenzonitrilu (0,80 g, 6 mmol, 1,5 ekv.). Aiztaisītā kolbā 15 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plāņslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (3:1).N - (6,6-Dimethyl-1-phenyl-4,5,6,7-tetrahydro-1 H -indazol-4-yl) -3-methoxy-benzamide 1-Phenyl-4-hydroxy-6, To a solution of 6-dimethyl-4,5,6,7-tetrabidroindazole (0.96 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (0.9 mL, 16 mmol) with magnetic stirrer. (4 eq.), Then m-methoxybenzonitrile (0.80 g, 6 mmol, 1.5 eq.) Was added dropwise. Continue stirring in a stoppered flask at 60 ° C for 15 hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (3: 1).

Iznākums: 0,81 g, (54%).Yield: 0.81 g (54%).

Balta cieta viela, Rf = 0,36 (T/E = 3/1)White solid, Rf = 0.36 (T / E = 3/1)

k.p. 140 °C (EtOH/H2O 3/1)bp 140 ° C (EtOH / H 2 O 3/1)

IS (KBr): 3339,2960,1641, 1602, 1581, 1527,1505, 1485,1406, 1295,1236, 1046.IS (KBr): 3339, 2960, 1641, 1602, 1581, 1527, 1505, 1485, 1406, 1295, 1236, 1046.

’H-KMR (300 MHz, CDC13) 6 (ppm): 7.64 (s, 1H, H-C(3)), 7.48-7.45 (m, 4H, Ph-N(l)), 7.44-7.41 (m,1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.64 (s, 1H, HC (3)), 7.48-7.45 (m, 4H, Ph-N (1)), 7.44-7.41 (m,

IH, Ar-C(l’)), 7.39-7.30 (m, 3H, Ph-N(l), Ar-C(l’)), 7.07-7.00 (m, 1H, Ar-C(l’)), 6.44 (d, 1H, 3J= 8.3 Hz, H-N-C(4)), 5.34 (ddd, 1H, 3J= 9.6 Hz, 3/= 8.3 Hz, 3J= 6.0 Hz, H-C(4)), 3.85 (s, 3H, m-CH3-O-ArC(l’)), 2.60 (d, 1H, 2J= 16.2 Hz, Ha-C(7)), 2.46 (d, 1H, 2J= 16.2 Hz, Hb-C(7)), 2.09 (dd, 1H, V= 12.9 Hz, 3J = 6.0 Hz, Ha-C(5)), 1.44 (dd, 1H, 2J= 12.9 Hz,3J= 9.6 Hz, Hb-C(5)), 1.12 (s, 3H, H3C-C(6)), 1.00 (s, 3H, H3C-C(6)).1H, Ar-C (l ')), 7.39-7.30 (m, 3H, Ph-N (l), Ar-C (l')), 7.07-7.00 (m, 1H, Ar-C (l ')) ), 6.44 (d, 1H, 3 J = 8.3 Hz, HNC (4)), 5.34 (ddd, 1H, 3 J = 9.6 Hz, 3 / = 8.3 Hz, 3 J = 6.0 Hz, HC (4)), 3.85 (s, 3H, m-CH 3 -O-ArC (1 ')), 2.60 (d, 1H, 2 J = 16.2 Hz, Ha-C (7)), 2.46 (d, 1H, 2 J = 16.2 Hz) , Hb-C (7)), 2.09 (dd, 1H, V = 12.9 Hz, 3 J = 6.0 Hz, Ha-C (5)), 1.44 (dd, 1H, 2 J = 12.9 Hz, 3 J = 9.6 Hz, Hb-C (5)), 1.12 (s, 3H, H 3 CC (6)), 1.00 (s, 3H, H 3 CC (6)).

3C-KMR (75 MHz, CDC13) δ (ppm): 166.9, 159.8, 139.5, 139.1, 138.0, 135.9, 129.5, 129.1, 127.2, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 166.9, 159.8, 139.5, 139.1, 138.0, 135.9, 129.5, 129.1, 127.2,

123.2, 118.6, 117.9,117.7,112.3,55.4,43.4,42.3, 36.9,32.7, 30.7,25.5.123.2, 118.6, 117.9,117.7,112.3,55,4,43.4,42.3, 36.9,32.7, 30.7,25.5.

Elementāranaīīze: aprēķināts C23H25N3O2 (375.19): C 73.57, H 6.71, N 11.19; atrasts C 73.33, H 6.72, NElementāranaīīze: calculated C 23 H 2 5 N 3 O 2 (375.19): C 73.57, H 6.71, N 11.19; found C 73.33, H 6.72, N

II. 07.II. 07

Piemērs 6.Example 6.

AL(6,6-DimetiI-l-fenil-4,5,6,7-tetrahidro-l//-indazol-4-il)-akrilamīds l-Fenil-4-hidroksi-6,6-dimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina akrilnitrilu (0,5 mL, 8 mmol, 2 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plāņslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).A L (6,6-dimethyl-l-phenyl-4,5,6,7-tetrahydro-l // - indazol-4-yl) -acrylamide l-Phenyl-4-hydroxy-6,6-dimethyl-4 To a solution of 5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (1.1 mL, 20 mmol, 5 equiv) with magnetic stirring. then add acrylonitrile (0.5 mL, 8 mmol, 2 equiv.). Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40-50 ° C and the pH is 10-11. The resin product initially solidifies gradually, recrystallizes from ethanol and water. (1: 1).

Iznākums: 0,84 g, (71%).Yield: 0.84 g (71%).

Balta cieta viela, Rf = 0,22 (T/E = 1/1)White solid, Rf = 0.22 (T / E = 1/1)

k.p. 190 °C (EtOH/H2O 1/1)bp 190 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3277, 3065, 2962, 2908, 1657, 1623, 1600, 1504, 1453, 1411, 1396, 1383, 1259, 1240, 1067, 990,967,954.IS (KBr): 3277, 3065, 2962, 2908, 1657, 1623, 1600, 1504, 1453, 1411, 1396, 1383, 1259, 1240, 1067, 990,967,954.

’H-KMR (300 MHz, CDC13) δ (ppm): 7.60 (s, 1H, H-C(3)), 7.48-7.44 (m, 4H, Ph-N(l)), 7.39-7.32 (m, 1H, Ph-N(l)), 6.33 (dd, 1H, 37= 17.0 Hz, 2J= 1.5 Hz, Ha-C(3’)), 6.12 (dd, 1H, 3J= 17.0 Hz, 3J= 10.2 Hz, H-C(2’)), 5.84 (d, 1H, 3J= 7.3 Hz, H-N-C(4)), 5.67 (dd, 1H, 3/ = 10.2 Hz, 2J= 1.5 Hz, Hb-C(3’)), 5.23 (ddd, 1H, V = 9.8 Hz, 3J= 7.3 Hz, 3/= 5.8 Hz, H-C(4)), 2.58 (d, 1H, 2J= 16.2 Hz, Ha-C(7)), 2.45 (d, 1H, 2J= 16.2 Hz, Hb-C(7)), 2.04 (dd, 1H, 2/= 13.0 Hz, 3J = 5.8 Hz, Ha-C(5)), 1.38 (dd, 1H, 2/= 13.0 Hz, 3J= 9.8 Hz, Hb-C(5)), 1.11 (s, 3H, H3C-C(6)), 0.98 (s, 3H, H3C-C(6)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.60 (s, 1H, HC (3)), 7.48-7.44 (m, 4H, Ph-N (1)), 7.39-7.32 (m, 1H, Ph-N (l)), 6:33 (dd, 1 H, 3 7 = 17.0 Hz, 2 J = 1.5 Hz, H-C (3 ')), 6.12 (dd, 1H, 3 J = 17.0 Hz, 3 J = 10.2 Hz, HC (2 ')), 5.84 (d, 1H, 3 J = 7.3 Hz, HNC (4)), 5.67 (dd, 1H, 3 / = 10.2 Hz, 2 J = 1.5 Hz, Hb- C (3 '), 5.23 (ddd, 1H, V = 9.8 Hz, 3 J = 7.3 Hz, 3 / = 5.8 Hz, HC (4)), 2.58 (d, 1H, 2 J = 16.2 Hz, C (7)), 2.45 (d, 1H, 2 J = 16.2 Hz, Hb-C (7)), 2.04 (dd, 1H, 2 / = 13.0 Hz, 3 J = 5.8 Hz, Ha-C (5) ), 1.38 (dd, 1H, 2 / = 13.0 Hz, 3 J = 9.8 Hz, H b -C (5)), 1.11 (s, 3H, H 3 CC (6)), 0.98 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDC13) δ (ppm): 165.1, 139.6, 139.3, 138.1, 130.9, 129.2, 127.2, 126.7, 123.3, 117.9,43.5,41.9,37.0,32.7,30.8,25.4. 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 165.1, 139.6, 139.3, 138.1, 130.9, 129.2, 127.2, 126.7, 123.3, 117.9,43.5,41.9,37.0,32.7,30.8,25.4.

Elementāranalīze: aprēķināts Ci8H21N3O (295.17): C 73.19, H 7.17, N 14.23; atrasts C 72.91, H 7.24, N 14.17.Elementāranalīze: calculated C 8 H 21 N 3 O (295.17): C 73.19, H 7.17, N 14:23; found C 72.91, H 7.24, N 14.17.

Piemērs 7.Example 7.

jV-(6,6-Dimetil-l-feniM,5,6,7-tetrahidro-l//-indazol-4-iI)-hloracetamīds l-Fenil-4-hidroksi-6,6-dimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (2,2 mL, 40 mmol, 10 ekv.), tad piepilina hloracetonitrilu (1,0 mL, 16 mmol, 4 ekv.). Aiztaisītā kolbā 25 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etilacetāta un heksāna (1:2). Iznākums: 0,87 g, (69%).N- (6,6-Dimethyl-1-phenyl, 5,6,7-tetrahydro-1 H -indazol-4-yl) -chloroacetamide 1-Phenyl-4-hydroxy-6,6-dimethyl-4,5 To a solution of 6,7-tetrahydro-indazole (0.96 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (2.2 mL, 40 mmol, 10 equiv) with magnetic stirring, then Chloroacetonitrile (1.0 mL, 16 mmol, 4 eq) was added. Continue stirring in a stoppered flask at 60 ° C for 25 hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40-50 ° C and the pH is 10-11. The resin product initially solidifies gradually, recrystallizes from ethyl acetate and hexane. (1: 2). Yield: 0.87 g (69%).

Balta cieta viela, Rf = 0,35 (T/E = 1/1) k.p. 173 °C (EtOAc/Hex 1/2)White solid R f = 0.35 (T / E = 1/1) kp 173 ° C (EtOAc / Hex 1/2)

IS (KBr): 3253, 3076,2961, 1648,1562,1505,1402,1249,1165,968.IS (KBr): 3253, 3076, 2961, 1648, 1562, 1505, 1402, 1249, 1165, 968.

’H-KMR (300 MHz, CDC13) δ (ppm): 7.62 (s, 1H, H-C(3)), 7.50-7.45 (m, 4H, Ph-N(l)), 7.40-7.33 (m, 1H, Ph-N(l)), 6.75 (d, 1H, 3J= 8.1 Hz, H-N-C(4)), 5.16 (ddd, 1H, V = 9.6 Hz, 3J = 8.1 Hz, 3J = 5.8 Hz, H-C(4)), 4.14 (d, 1H, 2J = 15.3 Hz, Ha-C(2’)), 4.08 (d, 1H, 2J= 15.3 Hz, Hb-C(2’)), 2.61 (d, 1H, 2J = 16.2 Hz, Ha-C(7)), 2.46 (d, 1H, 2J= 16.2 Hz, Hb-C(7)), 2.02 (dd, 1H, 2J= 13.0 Hz, V = 5.8 Hz, Ha-C(5)), 1.46 (dd, 1H, 2J= 13.0 Hz, 3J= 9.6 Hz, Hb-C(5)), 1.13 (s, 3H, H3C-C(6)), 0.99 (s, 3H, H3C-C(6)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.62 (s, 1H, HC (3)), 7.50-7.45 (m, 4H, Ph-N (1)), 7.40-7.33 (m, 1H, Ph-N (1)), 6.75 (d, 1H, 3 J = 8.1 Hz, HNC (4)), 5.16 (ddd, 1H, V = 9.6 Hz, 3 J = 8.1 Hz, 3 J = 5.8 Hz , HC (4)), 4.14 (d, 1H, 2 J = 15.3 Hz, Ha-C (2 ')), 4.08 (d, 1H, 2 J = 15.3 Hz, Hb-C (2')), 2.61 (d, 1H, 2 J = 16.2 Hz, Ha-C (7)), 2.46 (d, 1H, 2 J = 16.2 Hz, Hb-C (7)), 2.02 (dd, 1H, 2 J = 13.0 Hz) V = 5.8 Hz, H-C (5)), 1:46 (dd, 1H, 2 J = 13.0 Hz, 3 J = 9.6 Hz, H-C (5)), 1.13 (s, 3H, H 3 CC ( 6)), 0.99 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDC13) δ (ppm): 165.6, 139.5, 139.3, 137.9, 129.2, 127.4, 123.5, 117.2, 43.3, 42.7, 42.4, 36.9, 32.7, 30.6, 25.6. 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 165.6, 139.5, 139.3, 137.9, 129.2, 127.4, 123.5, 117.2, 43.3, 42.7, 42.4, 36.9, 32.7, 30.6, 25.6.

Elementāranalīze: aprēķināts Ci7H2oN3OCl (317.13): C 64.25, H 6.34, N 13.22; atrasts C 64.11, H 6.27, N 13.00.Elemental Analysis: Calculated for C 17 H 20 N 3 OCl (317.13): C 64.25, H 6.34, N 13.22; Found: C, 64.11; H, 6.27; N, 13.00.

Piemērs 8.Example 8.

A-(6,6-DimetiI-l-feniI-4,5,6,7-tetrahidro-l//-indazol-4-iI)-2-fluor-benzamīds l-Fenil-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina o-fluorbenzonitrilu (0,9 mL, 8 mmol, 2 ekv.). Aiztaisītā kolbā 25 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (6,6-Dimethyl-1-phenyl-4,5,6,7-tetrahydro-1 H -indazol-4-yl) -2-fluorobenzamide 1-Phenyl-4-hydroxy-3.6 To a solution of 6-trimethyl-4,5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (1.1 mL, 20 mL) with magnetic stirring. mmol, 5 eq.) then add o-fluorobenzonitrile (0.9 mL, 8 mmol, 2 eq.). Continue stirring in a stoppered flask at 60 ° C for 25 hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1,04 g, (69%).Yield: 1.04 g (69%).

Balta cieta viela, Rf = 0,48 (T/E =1/1)White solid, Rf = 0.48 (T / E = 1/1)

k. p. 69 °C (EtOH/H2O 1/1)b.p. 69 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3388, 3066,2951, 1648, 1616,1501,1396,1320, 1297, 1258,1219,1099, 968, 924.IS (KBr): 3388, 3066, 2951, 1648, 1616, 1501, 1396, 1320, 1297, 1258, 1219, 1099, 968, 924.

’H-KMR (300 MHz, CDC13) δ (ppm): 8.15 (dt, 1H, J= 7.9 Hz,/= 1.9 Hz, o-F-C6H4-C(l’)), 7.67 (s, 1H, H-C(3)), 7.52-7.43 (m, 5H, o-F-C6H4-C(l’), Ph-N(l)), 7.39-7.32 (m, 1H, Ph-N(l)), 7.30 (d, 1H, J = 7.7 Hz, o-F-C6H4-C(l’)), 7.11 (dd, 1H, 7= 12.2 Hz, 3J= 8.3 Hz, o-F-C6H4-C(l’)), 6.91 (dd, 1H, JN.F = 12.2 Hz, 3J= 8.9 Hz, H-N-C(4)), 5.40 (ddd, 1H, V = 9.4 Hz, 7= 8.5 Hz,3J= 5.8 Hz, H-C(4)), 2.63 (d, 1H, 2J= 15.8 Hz, Ha-C(7)), 2.49 (d, 1H, 7 = 15.8 Hz, Hb-C(7)), 2.14 (dd, 1H, 2J= 13.0 Hz, 3J= 5.8 Hz, H.-C(5)),1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 8.15 (dt, 1H, J = 7.9 Hz, / = 1.9 Hz, δFC 6 H 4 -C (1 ')), 7.67 (s, 1H, HC) (3)), 7.52-7.43 (m, 5H, oFC 6 H 4 -C (l '), Ph-N (l)), 7.39-7.32 (m, 1H, Ph-N (l)), 7.30 (d) , 1H, J = 7.7 Hz, F-C6H4-C (l ')), 7.11 (dd, 1 H, 7 = 12.2 Hz, 3 J = 8.3 Hz, F-C6H4-C (l')), 6.91 (dd , 1H, JN.F = 12.2 Hz, 3 J = 8.9 Hz, HNC (4)), 5.40 (ddd, 1H, V = 9.4 Hz, 7 = 8.5 Hz, 3 J = 5.8 Hz, HC (4)), 2.63 (d, 1H, 2 J = 15.8 Hz, Ha-C (7)), 2.49 (d, 1H, 7 = 15.8 Hz, H b -C (7)), 2.14 (dd, 1H, 2 J = 13.0) Hz, 3 J = 5.8 Hz, H-C (5)),

l. 53 (dd, 1H, 2J= 13.0 Hz, 3J= 9.4 Hz, Hb-C(5)), 1.14 (s, 3H, H3C-C(6)), 1.03 (s, 3H, H3C-C(6)).l. 53 (dd, 1H, 2 J = 13.0 Hz, 3 J = 9.4 Hz, H b -C (5)), 1.14 (s, 3H, H 3 CC (6)), 1.03 (s, 3H, H 3 CC) (6)).

13C-KMR (75 MHz, CDClj) δ (ppm): 163.0 (d, 7C-f = 3 Hz), 160.7 (d, JC-f = 247 Hz), 139.7, 139.2, 13 C-NMR (75 MHz, CDCl 3) δ (ppm): 163.0 (d, 7 C -f = 3 Hz), 160.7 (d, J C -f = 247 Hz), 139.7, 139.2,

138.1, 133.4 (d, 7c-f = 9 Hz), 132.1 (d, JC-f = 2 Hz), 129.2, 127.2, 124.9 (d, JC-f = 3 Hz), 123.4, 121.1 (d, Jc-f= 12 Hz), 117.8, 116.0 (d, JC-f = 25 Hz), 43.5, 42.4,37.0, 32.7, 30.6,25.8.138.1, 133.4 (d, 7c-f = 9 Hz), 132.1 (d, J C f = 2 Hz), 129.2, 127.2, 124.9 (d, J C f = 3 Hz), 123.4, 121.1 (d, Jc-f = 12 Hz), 117.8, 116.0 (d, J C -f = 25 Hz), 43.5, 42.4.37.0, 32.7, 30.6.25.8.

Elementāranalīze: aprēķināts C23H24N3OF (377.19): C 73.19, H 6.41, N 11.13; atrasts C 69.79, H 6.18, N 14.86.Elemental Analysis: Calculated for C23H24N3OF (377.19): C 73.19, H 6.41, N 11.13; Found: C 69.79, H 6.18, N 14.86.

Piemērs 9.Example 9.

/V-(3,6,6-TrimetiI-l-pirid-2-iI-4,5,6,7-tetrahidro-lZ7-indazol-4-il)-acetamīds l-(Pirid-2-il)-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina acetonitrilu (0,4 mL, 8 mmol, 2 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N - (3,6,6-Trimethyl-1-pyrid-2-yl-4,5,6,7-tetrahydro-1 H -indazol-4-yl) -acetamide 1- (Pyrid-2-yl) - To a solution of 4-hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv.) In glacial acetic acid (4 mL) was added concentrated sulfuric acid with stirring. (1.1 mL, 20 mmol, 5 equiv), then add acetonitrile (0.4 mL, 8 mmol, 2 equiv). Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1,04 g, (87%).Yield: 1.04 g (87%).

Balta cieta viela, Rf = 0,08 (T/E - l/l)White solid, Rf = 0.08 (T / E - 1 / l)

k. p. 160 °C (EtOH/H2O 1/1)bp 160 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3307, 3279, 2952, 1659, 1639, 1595, 1563,1557,1486, 1471, 1445, 1378, 1090, 1042. ’H-KMR (300 MHz, CDCI3) δ (ppm): 8.39 (ddd, 1H, 3J= 4.9 Hz, 4/= 1.9 Hz, V= 0.9 Hz, Py-N(l)), 7.83 (ddd, 1H, 3J = 8.5 Hz, 3J= 7.2 Hz, 4J = 0.9 Hz, Py-N(l)), 7.76 (ddd, 1H, 3J= 10.2 Hz, 3J= 7.2 Hz, 4J =IS (KBr): 3307, 3279, 2952, 1659, 1639, 1595, 1563, 1557, 1486, 1471, 1445, 1378, 1090, 1042. 1 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.39 ( ddd, 1H, 3 J = 4.9 Hz, 4 / = 1.9 Hz, V = 0.9 Hz, Py-N (1)), 7.83 (ddd, 1H, 3 J = 8.5 Hz, 3 J = 7.2 Hz, 4 J = 0.9 Hz, Py-N (l)), 7.76 (ddd, 1H, 3 J = 10.2 Hz, 3 J = 7.2 Hz, 4 J =

l. 9 Hz, Py-N(l)), 7.12 (ddd, 1H, 3J= 7.2 Hz, 3J= 4.9 Hz, 4J= 1.3 Hz, Py-N(l)), 5.64 (d, 1H, 3J= 9.2 Hz, H-N-C(4)), 5.16 (ddd, 1H, 3J= 9.2 Hz, 3J= 9.0 Hz, 3J= 6.0 Hz, H-C(4)), 2.95 (d, 1H, 2J= 17.7 Hz, HaC(7)), 2.87 (d, 1H, 2/ = 17.7 Hz, Hb-C(7)), 2.24 (s, 3H, H-C(2’)), 2.03 (s, 3H, H3C-C(3)), 1.89 (ddd, 1H, 2J= 13.0 Hz, 3J= 6.0 Hz, 4J= 0.9 Hz, Ha-C(5)), 1.29 (dd, 1H, 2J= 13.0 Hz, 3J= 9.0 Hz, Hb-C(5)) 1.09 (s, 3H, H3C-C(6)), 0.95 (s, 3H, H3C-C(6)).l. 9 Hz, Py-N (l)), 7.12 (ddd, 1H, 3 J = 7.2 Hz, 3 J = 4.9 Hz, 4 J = 1.3 Hz, Py-N (l)), 5.64 (d, 1H, 3 J = 9.2 Hz, HNC (4)), 5.16 (ddd, 1H, 3 J = 9.2 Hz, 3 J = 9.0 Hz, 3 J = 6.0 Hz, HC (4)), 2.95 (d, 1H, 2 J = 17.7 Hz, HAC (7)), 2.87 (d, 1 H, 2 / = 17.7 Hz, H-C (7)), 2.24 (s, 3H, HC (2 ')), 2:03 (s, 3H, H 3 CC (3)), 1.89 (ddd, 1H, 2 J = 13.0 Hz, 3 J = 6.0 Hz, 4 J = 0.9 Hz, Ha-C (5)), 1.29 (dd, 1H, 2 J = 13.0 Hz, 3 J = 9.0 Hz, H b -C (5)) 1.09 (s, 3H, H 3 CC (6)), 0.95 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDClj) δ (ppm): 169.2,153.0, 148.2,147.5,141.8, 138.3, 120.6,116.3,114.8,43.9, 41.3,38.8, 32.2, 30.6, 25.8,23.4,12.6. 13 C-NMR (75 MHz, CDCl 3) δ (ppm): 169.2,153.0, 148.2,147.5,141.8, 138.3, 120.6,116.3,114.8,43.9, 41.3,38.8, 32.2, 30.6, 25.8,23.4,12.6.

Elementāranalīze: aprēķināts C17H22N4O (298.13): C 68.43, H 7.43, N 18.78; atrasts C 68.44, H 7.49, N 18.74.Elemental Analysis: Calculated for C 17 H 22 N 4 O (298.13): C 68.43, H 7.43, N 18.78; found C 68.44, H 7.49, N 18.74.

Piemērs 10.Example 10.

7V-(3,6,6-Trimetil-l-pirid-2-il-4,5,6,7-tetrahidro-lH-indazol-4-a)-hloracetamīds l-(Pirid-2-il)-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (2,2 mL, 40 mmol, 10 ekv.), tad piepilina hloracetonitrilu (1,0 mL, 16 mmol, 4 ekv.). Aiztaisītā kolbā 11 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etilacetāta un heksāna (1:2).N- (3,6,6-Trimethyl-1-pyrid-2-yl-4,5,6,7-tetrahydro-1H-indazol-4-a) -chloroacetamide 1- (Pyrid-2-yl) -4 To a solution of -hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (magnetic stirring). 2.2 mL, 40 mmol, 10 equiv), then add chloroacetonitrile (1.0 mL, 16 mmol, 4 equiv). Continue to stir in the sealed flask for 11 hours at 60 ° C. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40-50 ° C and the pH is 10 11. 1: 2).

Iznākums: 1,01 g, (76%).Yield: 1.01 g (76%).

Balta cieta viela, Rf = 0,64 (T/E =1/3)White solid, Rf = 0.64 (T / E = 1/3)

k.p. 156 °C (EtOAc/Hex 1/2)p.p. 156 ° C (EtOAc / Hex 1/2)

IS (KBr): 3246, 3073, 2951, 2899, 2870, 1604, 1583, 1564, 1557, 1538, 1482, 1446, 1430, 1382, 1371, 1252.IS (KBr): 3246, 3073, 2951, 2899, 2870, 1604, 1583, 1564, 1557, 1538, 1482, 1446, 1430, 1382, 1371, 1252.

‘H-KMR (300 MHz, CDC13) δ (ppm): 8.39 (ddd, 1H, 3J= 4,9 Hz, 4J= 1.7 Hz, 5J= 0.8 Hz, Py-N(l)), 7.85 (dt, 1H, 4J= 8.3 Hz, 5J= 0.9 Py-N(l)), 7.77 (ddd, 1H, 3J= 8.3 Hz, 3J= 7.2 Hz, 4J = 1.9 Hz, Py-N(l)), 7.13 (ddd, 1H, 3J= 7.2 Hz, 3J= 4.9 Hz, 4/= 1.1 Hz, Py-N(l)), 6.63 (d, 1H, 3J = 8.9 Hz, H-N-C(4)), 5.19 (ddd, 1H, 3J = 8.9 Hz, 3J = 8.7 Hz, 3J= 6.0 Hz, H-C(4)), 4.11 (s, 2H, H-C(2’)), 3.00 (d, 1H, 2J = 17.7 Hz, H,C(7)), 2.93 (d, 1H, 2J= 17.7 Hz, Hb-C(7)), 2.25 (s, 3H, H-C-C(3)), 1.97 (ddd, 1H, 2J = 13.0 Hz, 3J= 6.0 Hz, 4J = 0.8 Hz, Ha-C(5)), 1.47 (dd, 1H, V= 13.2 Hz, 3J= 8.7 Hz, Hb-C(5)), 1.13 (s, 3H, H3C-C(6)), 1.00 (s, 3H, H3C-C(6)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 8.39 (ddd, 1H, 3 J = 4.9 Hz, 4 J = 1.7 Hz, 5 J = 0.8 Hz, Py-N (1)), 7.85 (dt, 1H, 4 J = 8.3 Hz, 5 J = 0.9 Py-N (1)), 7.77 (ddd, 1H, 3 J = 8.3 Hz, 3 J = 7.2 Hz, 4 J = 1.9 Hz, Py- N (l)), 7.13 (ddd, 1H, 3 J = 7.2 Hz, 3 J = 4.9 Hz, 4 / = 1.1 Hz, Py-N (l)), 6.63 (d, 1H, 3 J = 8.9 Hz, HNC (4)), 5.19 (ddd, 1H, 3 J = 8.9 Hz, 3 J = 8.7 Hz, 3 J = 6.0 Hz, HC (4)), 4.11 (s, 2H, HC (2 ')), 3.00 (d, 1H, 2 J = 17.7 Hz, H, C (7)), 2.93 (d, 1H, 2 J = 17.7 Hz, Hb-C (7)), 2.25 (s, 3H, HCC (3)) , 1.97 (ddd, 1H, 2 J = 13.0 Hz, 3 J = 6.0 Hz, 4 J = 0.8 Hz, Ha-C (5)), 1.47 (dd, 1H, V = 13.2 Hz, 3 J = 8.7 Hz, H b -C (5)), 1.13 (s, 3H, H 3 CC (6)), 1.00 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDC13) δ (ppm): 165.1, 153.1, 148.1, 147.5, 142.0, 138.3, 120.7, 115.5, 114.8,43.5, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 165.1, 153.1, 148.1, 147.5, 142.0, 138.3, 120.7, 115.5, 114.8,43.5,

42.6, 42.0, 38.8, 32.1, 30.3, 26.2, 12.6.42.6, 42.0, 38.8, 32.1, 30.3, 26.2, 12.6.

Elementāranalīze: aprēķināts CpHiiNļOCl (332.14): C 61.35, H 6.36, N 16.83; atrasts C 61.39, H 6.33, N 16.83.Elemental Analysis: Calculated for CpH11NlOCl (332.14): C, 61.35; H, 6.36; N, 16.83; Found: C 61.39, H 6.33, N 16.83.

Piemērs 11.Example 11.

A-(3,6,6-Trimetil-l-pirid-2-il-4,5,0,7-tetrahidr(>-l//-indazol-4-il)-trihloracetamīds l-(Pirid-2-il)-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina trihloracetonitrilu (4,0 mL, 40 mmol, 10 ekv.). Aiztaisītā kolbā 15 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (2:1). Iznākums: 0,99 g, (62%).N- (3,6,6-Trimethyl-1-pyrid-2-yl-4,5,0,7-tetrahydro-1H-indazol-4-yl) -trichloroacetamide 1- (Pyrid-2- yl) -4-Hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydro-indazole (0.96 g, 4 mmol, 1 eq) in glacial acetic acid (4 mL) under magnetic stirring, Add concentrated sulfuric acid (1.1 mL, 20 mmol, 5 equiv.) then add trichloroacetonitrile (4.0 mL, 40 mmol, 10 equiv.) Continue stirring in a stoppered flask for 15 hours at 60 ° C. Test the reaction solution on silica gel. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40-50 ° C and the pH is 10 11. The resin product initially solidified gradually, recrystallized from ethanol: water (2: 1) Yield: 0.99 g (62%).

Balta cieta viela, Rf = 0,41 (T/E = 3/2)White solid, Rf = 0.41 (T / E = 3/2)

k.p. 181 °C (EtOH/H2O 2/1)bp 181 ° C (EtOH / H 2 O 2/1)

IS (KBr): 3302, 2965, 2928, 2356,2343,1704,1681, 1595,1582,1520, 1485, 1471,1445,1430, 1382, 1371,1078,1041.IS (KBr): 3302, 2965, 2928, 2356, 2343, 1704, 1681, 1595, 1582, 1520, 1485, 1471, 1445, 1430, 1382, 1371, 1078, 1041.

‘H-KMR (300 MHz, CDC13) δ (ppm): 8.40 (d, 1H, 3J= 4.2 Hz, Py-N(l)), 7.85 (d, 1H, 3J = 8.2 Hz, PyN(l)), 7.77 (dd, 1H, 3J= 8.3 Hz, 3J= 7.3 Hz, Py-N(l)), 7.15 (dd, 1H, 3J= 7.2 Hz, 3J= 4.9 Hz, Py-N(l)), 6.74 (d, 1H, 3J= 8.7 Hz, H-N-C(4)), 5.13 (ddd, 1H, 3J= 8.7 Hz,3J= 8.3 Hz,3J= 6.0 Hz, H-C(4)), 2.99 (s, 2H, H-C(7)), 2.29 (s, 3H, H3C-C(3)), 2.02 (dd, 1H, 2J= 13.0 Hz,V= 6.0 Hz, Ha-C(5)), 1.53 (dd, 1H, 2J= 13.1 Hz,37= 8.3 Hz, Hb-C(5)), 1.14 (s, 3H, H3C-C(6)), 1.02 (s, 3H, H3C-C(6)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 8.40 (d, 1H, 3 J = 4.2 Hz, Py-N (1)), 7.85 (d, 1H, 3 J = 8.2 Hz, PyN ( l)), 7.77 (dd, 1H, 3 J = 8.3 Hz, 3 J = 7.3 Hz, Py-N (l)), 7.15 (dd, 1H, 3 J = 7.2 Hz, 3 J = 4.9 Hz, Py- N (1), 6.74 (d, 1H, 3 J = 8.7 Hz, HNC (4)), 5.13 (ddd, 1H, 3 J = 8.7 Hz, 3 J = 8.3 Hz, 3 J = 6.0 Hz, HC ( 4)), 2.99 (s, 2H, HC (7)), 2.29 (s, 3H, H3 C-C (3)), 2.02 (dd, 1H, 2 J = 13.0 Hz, V = 6.0 Hz, Ha-C (5)), (1.53, dd, 1H, 2 J = 13.1 Hz, 3 7 = 8.3 Hz, H b -C (5)), 1.14 (s, 3H, H 3 CC (6)), 1:02 (s, 3H, H 3 CC (6)).

13C-KMR(75 MHz, CDCi3) δ (ppm): 161.1, 153.1, 148.2, 147.6, 142.2, 138.4, 120.9, 114.9, 114.8, 92.8, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 161.1, 153.1, 148.2, 147.6, 142.2, 138.4, 120.9, 114.9, 114.8, 92.8,

44.1, 42.9, 38.7, 32.1, 30.1, 26.6, 12.7.44.1, 42.9, 38.7, 32.1, 30.1, 26.6, 12.7.

Elementāranalīze: aprēķināts C17H19N4OCI3 (400.06): C 50.83, H 4.77, N 13.95; atrasts C 50.86, H 4.63, N 13.82.Elemental Analysis: Calculated for C17H19N4OCl3 (400.06): C 50.83, H 4.77, N 13.95; Found: C 50.86, H 4.63, N 13.82.

Piemērs 12.Example 12.

A-(3,6,6-Trimetil-l-pirid-2-iM,5,6,7-tetrahidro-l//-indazol-4-il)-benzamīds l-(Pirid-2-il)-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina benzonitrilu (0,8 mL, 8 mmol, 2 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Trimethyl-1-pyrid-2-yl, 5,6,7-tetrahydro-1 H -indazol-4-yl) -benzamide 1- (Pyrid-2-yl) -4 To a solution of -hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (magnetic stirring). 1.1 mL, 20 mmol, 5 equiv), then add benzonitrile (0.8 mL, 8 mmol, 2 equiv). Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1,22 g, (85%).Yield: 1.22 g (85%).

Balta cieta viela, Rf = 0,55 (T/E = 1/1)White solid, Rf = 0.55 (T / E = 1/1)

k.p. 218 °C (EtOH/H2O 1/1)bp 218 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3291, 3060, 2946, 2927,2914, 1629, 1582, 1530, 1487, 1470,1445, 1429, 1382, 1268, 1319, 1301, 1286, 1178, 1148, 1075,1042.IS (KBr): 3291, 3060, 2946, 2927, 2914, 1629, 1582, 1530, 1487, 1470, 1445, 1429, 1382, 1268, 1319, 1301, 1286, 1178, 1148, 1075, 1042.

’H-KMR (300 MHz, CDClļ) δ (ppm): 8.41 (d, 1H, 3,/= 4.9 Hz, H-C(Ar)), 7.85-7.82 (m, 3H, H-C(Ar)), 7.75 (dd, 1H, 3J = 8.3 Hz, 4J= 1.9 Hz, H-C(Ar)), 7.53-7.41 (m, 3H, H-C(Ar)), 7.13 (dd, 1H, 3J = 7.2 Hz, 4J= 4.9 Hz, H-C(Ar)), 6.39 (d, 1H, 3J= 8.9 Hz, H-N-C(4)), 5.38 (ddd, 1H, V = 9.0 Hz, 3J = 8.9 Hz, 3J = 6.0 Hz, H-C(4)), 2.96 (s, 2H, H-C(7)), 2.24 (s, 3H, H3C-C(3)), 1.99 (dd, 1H, 2J= 13.0 Hz, 3J= 6.0 Hz, HaC(5)), 1.37 (dd, 1H, 2J= 13.0 Hz, 3J= 9.0 Hz, Hb-C(5)), 1.10 (s, 3H, H3C-C(6)), 0.99 (s, 3H, H3C-C(6)). 13C-KMR (75 MHz, CDC13) δ (ppm): 166.7, 153.1, 148.3, 147.5, 141.9, 138.3, 134.5, 131.5, 128.6, 126.8, 120.6,116.4,114.8,43.7,41.8,38.8, 32.2, 30.5,26.0,12.7.1 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.41 (d, 1H, 3 , δ = 4.9 Hz, HC (Ar)), 7.85-7.82 (m, 3H, HC (Ar)), 7.75 ( dd, 1H, 3 J = 8.3 Hz, 4 J = 1.9 Hz, HC (Ar)), 7.53-7.41 (m, 3H, HC (Ar)), 7.13 (dd, 1H, 3 J = 7.2 Hz, 4 J = 4.9 Hz, HC (Ar)), 6.39 (d, 1H, 3 J = 8.9 Hz, HNC (4)), 5.38 (ddd, 1H, V = 9.0 Hz, 3 J = 8.9 Hz, 3 J = 6.0 Hz , HC (4)), 2.96 (s, 2H, HC (7)), 2.24 (s, 3H, H3 C-C (3)), 1.99 (dd, 1H, 2 J = 13.0 Hz, 3 J = 6.0 Hz) , HaC (5)), 1.37 (dd, 1H, 2 J = 13.0 Hz, 3 J = 9.0 Hz, Hb-C (5)), 1.10 (s, 3H, H3 C-C (6)), 0.99 (s , 3H, H 3 C-C (6)). 13 C-NMR (75 MHz, CDCl3) δ (ppm): 166.7, 153.1, 148.3, 147.5, 141.9, 138.3, 134.5, 131.5, 128.6, 126.8, 120.6,116.4,114.8,43.7,41.8,38.8, 32.2, 30.5 , 26.0,12.7.

Elementāranalīze: aprēķināts C22H24N4O (360.20): C 73.31, H 6.71, N 15.54; atrasts C 73.37, H 6.73, N 15.59.Elemental Analysis: Calculated for C 22 H 24 N 4 O (360.20): C 73.31, H 6.71, N 15.54; found C 73.37, H 6.73, N 15.59.

Piemērs 13.Example 13.

7V-(3,6,6-Trinietil-l-pirid-2-il-4,5,6,7-tetrahidro-lji/-indazol-4-il)-akrilainīds l-(Pirid-2-il)-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina akrilnitrilu (0,5 mL, 8 mmol, 2 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Trinyl-1-pyrid-2-yl-4,5,6,7-tetrahydro-1H-indazol-4-yl) -acrylamide 1- (Pyrid-2-yl) - To a solution of 4-hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv.) In glacial acetic acid (4 mL) was added concentrated sulfuric acid with stirring. (1.1 mL, 20 mmol, 5 equiv), then add acrylonitrile (0.5 mL, 8 mmol, 2 equiv). Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1,00 g, (81 %).Yield: 1.00 g (81%).

Balta cieta viela, Rf = 0.24 (T/E =1/1)White solid, Rf = 0.24 (T / E = 1/1)

k.p. 177 °C (EtOH/H2O 1/1)bp 177 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3237, 3066,2950, 2932,1651,1621,1593, 1583,1549,1486,1470, 1446,1427, 1382,1366, 1320,1307,1249,1147,1134,1088,1069,1053,1042, 988,971.IS (KBr): 3237, 3066, 2950, 2932, 1651, 1621, 1593, 1583, 1549, 1486, 1470, 1446, 1427, 1382, 1366, 1320, 1307, 1249, 1147, 1134, 1088, 1069, 1053 , 1042, 988,971.

3H-KMR (300 MHz, CDC13) δ (ppm): 8.39 (d, 1H, 3J = 4.7 Hz, Py-N(l)), 7.82 (d, 1H, 3J= 8.3 Hz, PyN(l)), 7.75 (dd, 1H, 3J= 7.1 Hz, 4J= 1.9 Hz, Py-N(l)), 7.12 (dd, 1H, 3J= 7.0 Hz, 3J= 4.8 Hz, Py-N(l)), 6.33 (dd, 1H, 3J= 17.0 Hz, 2J = 1.9 Hz, Ha-C(3’)), 6.19 (dd, 1H, 2J = 17.0 Hz, 3J= 10.0 Hz, H-C(2’)), 6.10 (d, 1H, 3J= 9.4 Hz, H-N-C(4)), 5.67 (dd, 1H, 3J= 10.0 Hz, 2J= 1.9 Hz, Hb-C(3’)), 5.18 (ddd, 1H, 3J = 9.4 Hz, 3J= 9.4 Hz, 3J= 6.2 Hz, H-C(4)), 2.89 (s, 2H, 2H-C(7)), 2.19 (s, 3H, H3C-C(3)), 1.83 (dd, 1H, 2J = 13.0 Hz, 3J = 6,2 Hz, Ha-C(5)), 1.11 (dd, 1H, 2J= 13.0 Hz, 3J= 9.4 Hz, Hb-C(5)), 1.03 (s, 3H, H3CC(6)), 0.91 (s, 3H, H3C-C(6)). 3 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.39 (d, 1H, 3 J = 4.7 Hz, Py-N (1)), 7.82 (d, 1H, 3 J = 8.3 Hz, PyN (1 )), 7.75 (dd, 1H, 3 J = 7.1 Hz, 4 J = 1.9 Hz, Py-N (1)), 7.12 (dd, 1H, 3 J = 7.0 Hz, 3 J = 4.8 Hz, Py-N (l)), 6.33 (dd, 1H, 3 J = 17.0 Hz, 2 J = 1.9 Hz, Ha-C (3 ')), 6.19 (dd, 1H, 2 J = 17.0 Hz, 3 J = 10.0 Hz, HC (2 '), 6.10 (d, 1H, 3 J = 9.4 Hz, HNC (4)), 5.67 (dd, 1H, 3 J = 10.0 Hz, 2 J = 1.9 Hz, Hb-C (3'). ), 5.18 (ddd, 1H, 3 J = 9.4 Hz, 3 J = 9.4 Hz, 3 J = 6.2 Hz, HC (4)), 2.89 (s, 2H, 2H-C (7)), 2.19 (s, 3H, H3 C-C (3)), 1.83 (dd, 1H, 2 J = 13.0 Hz, 3 J = 6.2 Hz, Ha-C (5)), 1.11 (dd, 1H, 2 J = 13.0 Hz), 3 J = 9.4 Hz, H b -C (5)), 1.03 (s, 3H, H 3 CC (6)), 0.91 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDCI3) δ (ppm): 164.9, 153.0, 148.5, 147.6, 142.0, 138.4, 130.9, 126.6, 120.7, 13 C-NMR (75 MHz, CDCl 3) δ (ppm): 164.9, 153.0, 148.5, 147.6, 142.0, 138.4, 130.9, 126.6, 120.7,

116.2, 114.7,43.5,41.2, 38.8, 32.3, 30.6,25.7,12.7.116.2, 114.7,43.5,41.2, 38.8, 32.3, 30.6,25.7,12.7.

Elementāranalīze: aprēķināts CigH22N4O (310.18): C 69.65, H 7.14, N 18.05; atrasts C 69.77, H 7.15, N 18.15.Elemental Analysis: Calculated for C 18 H 22 N 4 O (310.18): C 69.65, H 7.14, N 18.05; found C 69.77, H 7.15, N 18.15.

Piemērs 14.Example 14.

7V-(3,6,6-TrimetiI-l-pirid-2-il-4,5,6,7-tetrahidro-ljH-indazol-4-il)-2-fluor-benzamīds l-(Pirid-2-il)-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrēta sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina o-fluorbenzonitrilu (0,9 mL, 8 mmol, 2 ekv.). Aiztaisītā kolbā 8 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Trimethyl-1-pyrid-2-yl-4,5,6,7-tetrahydro-1H-indazol-4-yl) -2-fluorobenzamide 1- (Pyrid-2- yl) -4-Hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydro-indazole (0.96 g, 4 mmol, 1 eq) in glacial acetic acid (4 mL) under magnetic stirring, Add concentrated sulfuric acid (1.1 mL, 20 mmol, 5 equiv) then add o-fluorobenzonitrile (0.9 mL, 8 mmol, 2 equiv). Continue stirring in a sealed flask for 8 hours at 60 ° C. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40-50 ° C and the pH is 1011. 1: 1).

Iznākums: 1,13 g, (75%).Yield: 1.13 g (75%).

Balta cieta viela, Rf = 0,52 (T/E =1/1)White solid, Rf = 0.52 (T / E = 1/1)

k. p. 174 °C (EtOH/H2O 1/1)bp 174 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3238, 2949, 1638, 1616,1583, 1552, 1536,1484, 1448, 1382, 1322, 1225.IS (KBr): 3238, 2949, 1638, 1616, 1583, 1552, 1536, 1484, 1448, 1382, 1322, 1225.

XH-KMR (300 MHz, CDC13) δ (ppm): 8.41 (pīs, 1H, Py-N(l)), 8.14 (td, 1H, J = 7.9 Hz, J= 1.9 Hz, ArC(l’)), 7.89 (d, 1H, J= Ί.Ί Hz, Py-N(l)), 7.78 (t, 1H, J- 8.0 Hz, Py-N(l)), 7.48 (m, 1H, Ar-C(l’)), 7.30 (d, 1H, J = 7.9 Hz, Ar-C(l’)), 7.15 (pls, 1H, Py-N(l)), 7.11 (dd, 1H, J= 12.2 Hz,7= 8.3 Hz, Ar-C(l’)), 6.78 (dd, 1H, JN.F = 12.2 Hz, 3J = 9.0 Hz, H-N-C(4)), 5.45 (ddd, 1H, 3J= 9.0 Hz, 7= 8.7 Hz,3J= 6.0 Hz, H-C(4)), 2.99 (s, 2H, H-C(7)), 2.29 (s, 3H, H3C-C(3)), 2.09 (dd, 1H, 3J= 13.2 Hz, 7 = 6.0 Hz, Η*<(5)), 1 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.41 (pis, 1H, Py-N (1)), 8.14 (td, 1H, J = 7.9 Hz, J = 1.9 Hz, ArC (1 ') ), 7.89 (d, 1H, J = Ί.Ί Hz, Py-N (l)), 7.78 (t, 1H, J = 8.0 Hz, Py-N (l)), 7.48 (m, 1H, Ar- C (l ')), 7.30 (d, 1H, J = 7.9 Hz, Ar-C (l')), 7.15 (pls, 1H, Py-N (l)), 7.11 (dd, 1H, J = 12.2 Hz, 7 = 8.3 Hz, Ar-C (1 ')), 6.78 (dd, 1H, JN.F = 12.2 Hz, 3 J = 9.0 Hz, HNC (4)), 5.45 (ddd, 1H, 3 J = 9.0 Hz, 7 = 8.7 Hz, 3 J = 6.0 Hz, HC (4), 2.99 (s, 2H, HC (7)), 2.29 (s, 3H, H3 C-C (3)), 2.09 (dd, 1H, 3 J = 13.2 Hz, 7 = 6.0 Hz, Η * <(5)),

l. 57 (dd, 1H, 3J= 13.2 Hz,7= 8.7 Hz, Hb-C(5)), 1.15 (s, 3H, H3C-C(6)), 1.05 (s, 3H, H3C-C(6)). 13C-KMR (75 MHz, CDCb) δ (ppm): 162.6 (d, JC-f = 3 Hz), 160.5 (d, 7C-f = 247 Hz), 153.1, 148.2, 147.5, 141.9, 138.1, 133.3 (d, 7C-f = 9 Hz), 132.1 (d, 7C-f = 2 Hz), 126.8, 124.9 (d, 7C.F = 3 Hz), 121.0 (d, 7C-f = 11 Hz), 120.6,116.0 (d, 7C-f = 25 Hz), 114.9,43.5,41.7, 38.6,32.0, 30.1, 26.2,12.3.l. 57 (dd, 1H, 3 J = 13.2 Hz, 7 = 8.7 Hz, Hb-C (5)), 1.15 (s, 3H, H3C-C (6)), 1.05 (s, 3H, H3C-C (6) )). 13 C-NMR (75 MHz, CDCl 3) δ (ppm): 162.6 (d, J C -f = 3 Hz), 160.5 (d, 7 C -f = 247 Hz), 153.1, 148.2, 147.5, 141.9, 138.1, 133.3 (d, C 7 f = 9 Hz), 132.1 (d, C f 7 = 2 Hz), 126.8, 124.9 (d, 7 C. F = 3 Hz), 121.0 (d, 7 = C f 11 Hz), 120.6.116.0 (d, 7 C -f = 25 Hz), 114.9,43.5,41.7, 38.6,32.0, 30.1, 26.2,12.3.

Elementāranalīze: aprēķināts C22H23N4OF (378.19): C 69.82, H 6.13, N 14.80; atrasts C 69.79, H 6.18, N 14.86.Elemental Analysis: Calculated for C 22 H 23 N 4 OF (378.19): C 69.82, H 6.13, N 14.80; Found: C 69.79, H 6.18, N 14.86.

Piemērs 15.Example 15.

/V-(3,6,6-Triinetil-l-pirid-2-iI-4,5,6,7-tetrahidro-l//-indazoI-4-iI)-butirainīds l-(Pirid-2-il)A-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (2,2 ml., 40 mmol, 10 ekv.), tad piepilina «-butilnitrilu (1,7 mL, 20 mmol, 5 ekv.). Aiztaisītā kolbā 8 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Triinethyl-1-pyrid-2-yl-4,5,6,7-tetrahydro-1 H -indazol-4-yl) -butyrainide 1- (Pyrid-2-yl) ) To a solution of A-hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv.) In glacial acetic acid (4 mL) was added concentrated magnetic stirring. sulfuric acid (2.2 mL, 40 mmol, 10 equiv), then dropwise tert-butyl nitrile (1.7 mL, 20 mmol, 5 equiv). Continue stirring in a sealed flask for 8 hours at 60 ° C. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 0,99 g, (76%).Yield: 0.99 g (76%).

Balta cieta viela, Rf= 0,18 (T/E = 1/1)White solid, Rf = 0.18 (T / E = 1/1)

k.p. 165 °C (EtOH/H2O 1/1)bp 165 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3232,3063,2957, 2927,2871,1639, 1584,1557, 1486,1470,1443,1382,1366,1216, 1058, 1040.IS (KBr): 3232, 3063, 2957, 2927, 2871, 1639, 1584, 1557, 1486, 1470, 1443, 1382, 1366, 1216, 1058, 1040.

3H-KMR (300 MHz, CDCb) δ (ppm): 8.39 (d, 1H, 3J= 5.7 Hz, Py-N(l)), 7.84 (d, 1H, 3J= 8.7 Hz, PyN(l)), 7.76 (t, 1H, 7 = 7.2 Hz, Py-N(l)), 7.13 (ddd, 1H, 3J = 7.2 Hz, 7 = 4.9 Hz, 7= 1.1 Hz, Py-N(l)), 5.67 (d, 1H, 7= 9.0 Hz, H-N-C(4)), 5.17 (ddd, 1H, 7= 9.0 Hz, 7= 9.0 Hz, 7= 6.0 Hz, H-C(4)), 2.90 (s, 2H, H-C(7)), 2.25 (s, 3H, H3C-C(3)), 2.21 (dd, 2H, 7= 14.5 Hz, 7= 8.1 Hz, H-C(2’)), 1.90 (dd, 1H, 7= 13.0 Hz,7= 6.0 Hz,Hb-C(5)), 1.70 (hex, 2H, 7= 7.5 Hz, H-C(3’)), 1.29 (dd, 1H, 7= 13.0 Hz,7= 9.0 Hz, Hb-C(5)), 1.08 (s, 3H, H3C-C(6)), 0.97 (t, 3H, 7= 7.3 Hz, H-C(4’)), 0.95 (s, 3H, H3C-C(6)). 3 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.39 (d, 1H, 3 J = 5.7 Hz, Py-N (1)), 7.84 (d, 1H, 3 J = 8.7 Hz, PyN (1 )), 7.76 (t, 1H, δ = 7.2 Hz, Py-N (l)), 7.13 (ddd, 1H, 3 J = 7.2 Hz, 7 = 4.9 Hz, 7 = 1.1 Hz, Py-N (l) ), 5.67 (d, 1H, J = 9.0 Hz, HNC (4)), 5.17 (ddd, 1H, J = 9.0 Hz, 7 = 9.0 Hz, 7 = 6.0 Hz, HC (4)), 2.90 (s, 2H, HC (7)), 2.25 (s, 3H, H 3 CC (3)), 2.21 (dd, 2H, 7 = 14.5 Hz, 7 = 8.1 Hz, HC (2 ')), 1.90 (dd, 1H , 7 = 13.0 Hz, 7 = 6.0 Hz, H b -C (5)), 1.70 (hex, 2H, 7 = 7.5 Hz, HC (3 ')), 1.29 (dd, 1H, 7 = 13.0 Hz, 7 = 9.0 Hz, H b -C (5)), 1.08 (s, 3H, H 3 CC (6)), 0.97 (t, 3H, 7 = 7.3 Hz, HC (4 ')), 0.95 (s, 3H) , H 3 CC (6)).

13C-KMR (75 MHz, CDCb) δ (ppm): 172.2,152.9, 148.2, 147.5,141.9, 138.3, 120.7, 116.4, 114.9, 43.9, 13 C-NMR (75 MHz, CDCl 3) δ (ppm): 172.2,152.9, 148.2, 147.5,141.9, 138.3, 120.7, 116.4, 114.9, 43.9,

41.1,38.8,38.7,32.2,30.5,25.9,19.2,13.8,12.6.41.1,38.8,38.7,32.2,30.5,25.9,19.2,13.8,12.6.

Elementāranalīze: aprēķināts C19H26N4O (326.45): C 69.90, H 8.03, N 17.16; atrasts C 69.89, H 8.08, N 17.24.Elemental Analysis: Calculated for C 19 H 26 N 4 O (326.45): C 69.90, H 8.03, N 17.16; found C 69.89, H 8.08, N 17.24.

Piemērs 16.Example 16.

/V-(3,6,6-Trimetil-l-pirid-2-il-4,5,6,7-tetraliidro-lfl-indazol-4-iI)-4-nitro-benzamīds l-(Pirid-2-il)-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina p-nitrobenzoitrilu (1,18 g, 8 mmol, 2 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūra turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1). Iznākums: 1,20 g, (74%).N- (3,6,6-Trimethyl-1-pyrid-2-yl-4,5,6,7-tetralidro-1 H -indazol-4-yl) -4-nitrobenzamide 1- (Pyrid-2) -yl) -4-hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv) in a solution of glacial acetic acid (4 mL) with magnetic stirrer , add concentrated sulfuric acid (1.1 mL, 20 mmol, 5 equiv), then add p-nitrobenzoyl tril (1.18 g, 8 mmol, 2 equiv). The closed flask is maintained at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40-50 ° C and the pH is 1011. 1: 1). Yield: 1.20 g (74%).

Balta cieta viela, Rf= 0,68 (Ί7Ε = 1/1) k.p. 196 °C (EtOH/H2O 1/1)White solid Rf = 0.68 (Ί7Ε = 1/1) kp 196 ° C (EtOH / H 2 O 1/1)

IS(KBr): 3216,2956, 2926, 1633, 1598, 1583, 1529, 1484,1447, 1390,1382, 1368, 1346, 1321,1047. ^I-KMR (300 MHz, CDCl·,) δ (ppm): 8.42 (d, 1H, 3J = 4.7 Hz, Py-N(l)), 8.29 (d, 2H, 3J = 8.7 Hz, pO2N-C6H4-C(1’)), 8.04 (d, 2H, 3J= 4.7 Hz, p-O2N-C6H4-C(l’)), 7.78 (d, 111,7- 8.1 Hz, Py-N(l)), 7.76 (dd, 1H, 3J= 8.5 Hz, V= 1.7 Hz, Py-N(l)), 7.15 (dd, 1H, 7= 6.6 Hz, 3J= 4.9 Hz, Py-N(l)), 6.68 (d, 1H, 3J= 9.0 Hz, H-N(4)), 5.34 (ddd, 1H, 3J= 9.4 Hz, 3J= 9.0 Hz, 7 = 6.2 Hz, H-C(4)), 2.94 (s, 2H, H-C(7)), 2.19 (s, 3H, H3C-C(3)), 1.95 (dd, 1H, 2J= 13.0 Hz, 3J= 6.2 Hz, Ha-C(5)), 1.26 (dd, 1H, 2J = 13.1 Hz, 3J= 9.4 Hz, Hb-C(5)), 1.09 (s, 3H, H3C-C(6)), 0.96 (s, 3H, H3C-C(6)).IS (KBr): 3216, 2956, 2926, 1633, 1598, 1583, 1529, 1484, 1447, 1390, 1382, 1368, 1346, 1321, 1047. 1 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.42 (d, 1H, 3 J = 4.7 Hz, Py-N (1)), 8.29 (d, 2H, 3 J = 8.7 Hz, pO2N -C 6 H 4 -C (1 ')), 8.04 (d, 2H, 3 J = 4.7 Hz, p-O 2 N-C 6 H 4 -C (1')), 7.78 (d, 111.7- 8.1 Hz, Py- N (l)), 7.76 (dd, 1H, 3 J = 8.5 Hz, V = 1.7 Hz, Py-N (l)), 7.15 (dd, 1H, 7 = 6.6 Hz, 3 J = 4.9 Hz, Py- N (I), 6.68 (d, 1H, 3 J = 9.0 Hz, HN (4)), 5.34 (ddd, 1H, 3 J = 9.4 Hz, 3 J = 9.0 Hz, 7 = 6.2 Hz, HC (4 ), 2.94 (s, 2H, HC (7)), 2.19 (s, 3H, H3 C-C (3)), 1.95 (dd, 1H, 2 J = 13.0 Hz, 3 J = 6.2 Hz, Ha-C (5)), 1.26 (dd, 1H, 2 J = 13.1 Hz, 3 J = 9.4 Hz, H b -C (5)), 1.09 (s, 3H, H 3 CC (6)), 0.96 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDC13) δ (ppm): 164.6, 152.9, 149.6, 148.2, 147.7, 142.2, 140.0, 138.5, 128.2, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 164.6, 152.9, 149.6, 148.2, 147.7, 142.2, 140.0, 138.5, 128.2,

123.9, 120.9, 115.8, 114.8,43.5, 42.3, 38.7, 32.3, 30.6,25.8, 12.8.123.9, 120.9, 115.8, 114.8,43.5, 42.3, 38.7, 32.3, 30.6,25.8, 12.8.

Elementāranalīze: aprēķināts C22H23N5O3 (405.18): C 65.17, H 5.72, N 17.27; atrasts C 65.10, H 5.68, N 17.23.Elemental Analysis: Calculated for C 22 H 23 N 5 O 3 (405.18): C 65.17, H 5.72, N 17.27; found C 65.10, H 5.68, N 17.23.

Piemērs 17.Example 17.

/V-(3,6,6-Trinietil-l-pirid-2-il-4,5,6,7-tetrahidro-lLf-indazol-4-il)-3-metoksi-benzaniīds l-(Pirid-2-il)-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina τη-metoksibenzonitrilu (0,80 g, 6 mmol, 1,5 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1). Iznākums: 1.22 g, (78%).N - (3,6,6-Trinyl-1-pyrid-2-yl-4,5,6,7-tetrahydro-11 H -indazol-4-yl) -3-methoxy-benzanide 1- (Pyrid-2) -yl) -4-hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv) in a solution of glacial acetic acid (4 mL) with magnetic stirrer , add concentrated sulfuric acid (1.1 mL, 20 mmol, 5 equiv), then add τη-methoxybenzonitrile (0.80 g, 6 mmol, 1.5 equiv). Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40-50 ° C and the pH is 1011. 1: 1). Yield: 1.22 g (78%).

Balta cieta viela, Rf = 0,59 (T/E =1/1)White solid, Rf = 0.59 (T / E = 1/1)

k.p. 149 °C (EtOH/H2O 1/1)b.p. 149 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3278,2959, 2929, 2869, 2835, 1637, 1609, 1583, 1550, 1487, 1445, 1390, 1381, 1369, 1323, 1301,1243, 1142,1133,1088, 1059,1039,989.IS (KBr): 3278, 2959, 2929, 2869, 2835, 1637, 1609, 1583, 1550, 1487, 1445, 1390, 1381, 1369, 1323, 1301, 1243, 1142, 1133, 1088, 1059, 1039, 989 .

XH-KMR (300 MHz, CDC13) δ (ppm): 8.39 (d, 1H, 3J = 4,9 Hz, Py-N(l)), 7.81 (d, 1H, 3J = 8.1 Hz, HC(Ar)), 7.72 (dd, 1H, 3J= 7.2 Hz, 7= 1.9 Hz, H-C(Ar)), 7.46 (d, 1H, 3J= 2.3 Hz, 3J= 1.5 Hz, H-C(Ar)), 7.39 (dt, 1H, 3J= 7.7 Hz, 3J= 1.1 Hz, H-C(Ar)), 7.31 (t, 1H, 3J= 7.9 Hz, H-C(Ar)), 7.11 (ddd, 1H, 3J = 7.0 Hz, 3J= 4.9 Hz, 4J= 0.9 Hz, H-C(Ar)), 7.03 (ddd, 1H, 3J= 7.9 Hz, AJ= 2.5 Hz, 7= 0.9 Hz, H-C(Ar)), 6.55 (d, 1H, 3J= 9.0 Hz, H-N-C(4)), 5.33 (ddd, 1H, 3J= 9.2 Hz, 3J= 9.0 Hz, 3J= 6.0 Hz, H-C(4)), 3.84 (s, 3H, m-CH3-O-C6H4-C(l’)), 2.93 (s, 2H, H-C(7)), 2.21 (s, 3H, H3C-C(3)), 1.92 (dd, 1H, 2J= 13.0 Hz, 3J= 6.0 Hz, Ha-C(5)), 1.23 (dd, 1H, 7 = 13.0 Hz, 3J= 9.2 Hz, Hb-C(5)), 1.06 (s, 3H, H3C-C(6)), 0,95 (s, 3H, H3C-C(6)). 1 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.39 (d, 1H, 3 J = 4.9 Hz, Py-N (1)), 7.81 (d, 1H, 3 J = 8.1 Hz, HC) (Ar)), 7.72 (dd, 1H, 3 J = 7.2 Hz, 7 = 1.9 Hz, HC (Ar)), 7.46 (d, 1H, 3 J = 2.3 Hz, 3 J = 1.5 Hz, HC (Ar)) ), 7.39 (dt, 1H, 3 J = 7.7 Hz, 3 J = 1.1 Hz, HC (Ar)), 7.31 (t, 1H, 3 J = 7.9 Hz, HC (Ar)), 7.11 (ddd, 1H, 3 J = 7.0 Hz, 3 J = 4.9 Hz, 4 J = 0.9 Hz, HC (Ar)), 7.03 (ddd, 1H, 3 J = 7.9 Hz, A J = 2.5 Hz, 7 = 0.9 Hz, HC (Ar) )), 6.55 (d, 1H, 3 J = 9.0 Hz, HNC (4)), 5.33 (ddd, 1H, 3 J = 9.2 Hz, 3 J = 9.0 Hz, 3 J = 6.0 Hz, HC (4)) , 3.84 (s, 3H, m-CH 3 -OC 6 H 4 -C (1 ')), 2.93 (s, 2H, HC (7)), 2.21 (s, 3H, H 3 CC (3)), 1.92 ( dd, 1H, 2 J = 13.0 Hz, 3 J = 6.0 Hz, Ha-C (5)), 1.23 (dd, 1H, 7 = 13.0 Hz, 3 J = 9.2 Hz, Hb-C (5)), 1.06 (s, 3H, H 3 CC (6)), 0.95 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDC13) δ (ppm): 166.5, 159.9, 153.1, 148.5, 147.6, 142.0, 138.4, 136.0, 129.6, 120.6,118.7, 117.7, 116.4,114.7, 112.4,55.5,43.5,41.8, 38.8, 32.3,30.6,25.9, 12.8. 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 166.5, 159.9, 153.1, 148.5, 147.6, 142.0, 138.4, 136.0, 129.6, 120.6, 118.7, 117.7, 116.4, 114.7, 112.4, 55.53.53, 41.8, 38.8, 32.3,30.6,25.9, 12.8.

Elementāranalīze: aprēķināts C23H26N4Ū3 (390.21): C 70.75, H 6.71, N 14.35; atrasts C 70.46, H 6.67, N 14.29.Elemental Analysis: Calculated for C 23 H 26 N 4 O 3 (390.21): C 70.75, H 6.71, N 14.35; found C 70.46, H 6.67, N 14.29.

Piemērs 18.Example 18.

/V-(3,6,6-Trimetil-l-fenil-4,5,6,7-tetrahidro-l//-indazol-4-il)-acetaniīds l-Fenil-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (1,02 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, ekv.), tad piepilina acetonitrilu (0.6 mL, 12 mmol, 3 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pāricristalizē no etanola un ūdens (1:1).N - (3,6,6-Trimethyl-1-phenyl-4,5,6,7-tetrahydro-1 H -indazol-4-yl) -acetanide 1-Phenyl-4-hydroxy-3,6, To a solution of 6-trimethyl-4,5,6,7-tetrahydroindazole (1.02 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (1.1 mL, 20 mmol) with magnetic stirrer. , eq.), then acetonitrile (0.6 mL, 12 mmol, 3 eq.) was added. Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 0.85 g, (76%).Yield: 0.85 g (76%).

Balta kristāliska viela Rf = 0.12 (T/E 1/2) k.p. 196 °C (EtOH/H2O 1/1)White crystalline substance Rf = 0.12 (T / E 1/2) bp 196 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3248,3058,2948, 2369,1636, 1560,1507,1381,1292, 1109,1039,1014.IS (KBr): 3248, 3058, 2948, 2369, 1636, 1560, 1507, 1381, 1292, 1109, 1039, 1014.

’H-KMR (300 MHz, CDC13) δ (ppm): 7.45-7.39 (m, 4H, Ph-N(l)), 7.33-7.27 (m, 1H, Ph-N(l)), 5.76 (d, 1H, 3J= 8.9 Hz, H-N-C(4)), 5.16 (dt, 1H, 3J= 8.9 Hz, 3J= 6.2 Hz, H-C(4)), 2.54 (d, 1H, 2J= 16.2 Hz, HaC(7)), 2.37 (d, 1H, 2J= 16.2 Hz, Hb-C(7)), 2.23 (s, 3H, H3C-C(3)), 1.99 (s, 3H, H-C(2’)), 1.95 (dd, 1H, 2J = 13.2 Hz, 3J= 6.2 Hz, Ha-C(5)), 1.37 (dd, 1H, 2J = 13.2 Hz, 3J = 8.9 Hz, Hb-C(5)), 1.06 (s, 3H, H3CC(6)), 0.92 (s, 3H, H3C-C(6)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.45-7.39 (m, 4H, Ph-N (1)), 7.33-7.27 (m, 1H, Ph-N (1)), 5.76 ( d, 1H, 3 J = 8.9 Hz, HNC (4)), 5.16 (dt, 1H, 3 J = 8.9 Hz, 3 J = 6.2 Hz, HC (4)), 2.54 (d, 1H, 2 J = 16.2 Hz, HaC (7)), 2.37 (d, 1H, 2 J = 16.2 Hz, Hb-C (7)), 2.23 (s, 3H, H3C-C (3)), 1.99 (s, 3H, HC ( 2 ')), 1.95 (dd, 1H, 2 J = 13.2 Hz, 3 J = 6.2 Hz, Ha-C (5)), 1.37 (dd, 1H, 2 J = 13.2 Hz, 3 J = 8.9 Hz, Hb -C (5)), 1.06 (s, 3H, H 3 CC (6)), 0.92 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDC13) δ (ppm): 169.3, 147.1, 140.0, 139.4, 129.2, 126.9, 123.1, 115.0, 44.0, 41.5, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 169.3, 147.1, 140.0, 139.4, 129.2, 126.9, 123.1, 115.0, 44.0, 41.5,

37.2, 32.7, 30.4,25.8, 23.4,12.4.37.2, 32.7, 30.4,25.8, 23.4,12.4.

Elementāranalīze: aprēķināts CieH23N3O (297.18): C 72.70, H 7.80, N 14.13; atrasts C 72.76, H 7.86, N 14.17.Elemental Analysis: Calculated for C 23 H 23 N 3 O (297.18): C 72.70, H 7.80, N 14.13; found C 72.76, H 7.86, N 14.17.

Piemērs 19.Example 19.

7V-(3,6,6-Trimetil-l-fenil-4,5,6,7-tetrahidro-l//-indazol-4-iI)-akrilamīds l-Fenil-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (1,02 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina akrilnitrilu (0,5 mL, 8 mmol, 2 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Trimethyl-1-phenyl-4,5,6,7-tetrahydro-1 H -indazol-4-yl) -acrylamide 1-Phenyl-4-hydroxy-3,6,6 Concentrated sulfuric acid (1.1 mL, 20 mmol) was added to a solution of -trimethyl-4,5,6,7-tetrahydroindazole (1.02 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) with magnetic stirring. 5 eq.), Then acrylonitrile (0.5 mL, 8 mmol, 2 eq.) Was added. Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 0,89 g, (66%).Yield: 0.89 g (66%).

Viegli iedzeltena cieta viela, Rf = 0.16 (T/E = 2/1)Light yellow solid, Rf = 0.16 (T / E = 2/1)

k.p. 150°C (EtOH/H2O 1/1)bp 150 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3434, 3050, 2956,2370,2345, 1656,1558,1251.IS (KBr): 3434, 3050, 2956, 2370, 2345, 1656, 1558, 1251.

’H-KMR (300 MHz, CDC13) δ (ppm): 7.47-7.41 (m, 4H, Ph-N(l)), 7.34-7.28 (m, 1H, Ph-N(l)), 6.32 (d, 1H, 3J= 16.8 Hz, Ha-C(3’)), 6.11 (dd, 1H, 3J = 16.9 Hz, 3J= 10.2 Hz, H-C(2’)), 5.74 (d, 1H, 3J= 8.9 Hz, H-N-C(4)), 5.67 (d, 1H, 3J= 10.2 Hz, Hb-C(3’)), 5.28 (ddd, 1H, 3J = 8.9 Hz, 3J= 8.7 Hz, 3J= 6.2 Hz, HC(4)), 2.58 (d, 1H, 2J = 16.2 Hz, Ha-C(7)), 2.40 (d, 1H, 2J= 16.2 Hz, Hb-C(7)), 2.23 (s, 3H, H3C-C(3)), 2.02 (dd, 1H, 2J= 13.3 Hz, 3J= 6.2 Hz, Ha-C(5)), 1.45 (dd, 1H, = 13.2 Hz, 3J= 8.7 Hz, Hb-C(5)), 1.08 (s, 3H, H3C-C(6)), 0.96 (s, 3H, H3C-C(6)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.47-7.41 (m, 4H, Ph-N (1)), 7.34-7.28 (m, 1H, Ph-N (1)), 6.32 ( d, 1H, 3 J = 16.8 Hz, Ha-C (3 ')), 6.11 (dd, 1H, 3 J = 16.9 Hz, 3 J = 10.2 Hz, HC (2')), 5.74 (d, 1H, 3 J = 8.9 Hz, HNC (4)), 5.67 (d, 1H, 3 J = 10.2 Hz, Hb-C (3 ')), 5.28 (ddd, 1H, 3 J = 8.9 Hz, 3 J = 8.7 Hz) , 3 J = 6.2 Hz, HC (4)), 2.58 (d, 1H, 2 J = 16.2 Hz, Ha-C (7)), 2.40 (d, 1H, 2 J = 16.2 Hz, Hb-C (7 )) 2.23 (s, 3H, H 3 CC (3)), 2:02 (dd, 1H, 2 J = 13.3 Hz, 3 J = 6.2 Hz, H-C (5)), 1:45 (dd, 1H, = 13.2 Hz, 3 J = 8.7 Hz, H-C (5)), 1:08 (s, 3H, H 3 CC (6)), 0.96 (s, 3H, H 3 CC (6)).

3C-KMR (75 MHz, CDC13) δ (ppm): 164.9, 147.3, 140.1, 139.4, 130.8, 129.2, 126.9, 126.7, 123.2, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 164.9, 147.3, 140.1, 139.4, 130.8, 129.2, 126.9, 126.7, 123.2,

114.8,43.9,41.6, 37.2, 32.7, 30.3, 25.9, 12.4.114.8,43.9,41.6, 37.2, 32.7, 30.3, 25.9, 12.4.

Elementāranalīze: aprēķināts Cj9H23N3O1.5 H2O (336.18): C 67.83, H 7.79, N 12.49; atrasts C 67.58, H 7.71, N 12.59.Elemental Analysis: Calculated for C 19 H 23 N 3 O 1.5 H 2 O (336.18): C 67.83, H 7.79, N 12.49; found C 67.58, H 7.71, N 12.59.

Piemērs 20.Example 20.

7V-(3,6,6-Trimetil-l-fenil-4,5,6,7-tetrahidro-lJī-indazol-4-il)-propionamīds l-Fenil-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (1,02 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, ekv.), tad piepilina etilnitrilu (1.4 mL, 20 mmol, 5 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfījas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Trimethyl-1-phenyl-4,5,6,7-tetrahydro-1H-indazol-4-yl) -propionamide 1-Phenyl-4-hydroxy-3,6,6-trimethyl To a solution of -4,5,6,7-tetrahydroindazole (1.02 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (1.1 mL, 20 mmol, equiv.) With magnetic stirring. ), then add ethyl nitrile (1.4 mL, 20 mmol, 5 equiv.). Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1,05 g, (79%).Yield: 1.05 g (79%).

Viegli iedzeltena cieta viela, Rf = 0.08 (T/E = 2/1)Light yellow solid, Rf = 0.08 (T / E = 2/1)

k. p. 147 °C (EtOH/H2O 1/1)bp 147 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3463, 3219, 3066,2955, 2931, 1656, 1648,1559, 1507, 1389, 1267,1110,1052.IS (KBr): 3463, 3219, 3066, 2955, 2931, 1656, 1648, 1559, 1507, 1389, 1267, 1110, 1052.

’H-KMR (300 MHz, CDC13) δ (ppm): 7.45-7.40 (m, 4H, Ph-N(l)), 7.34-7.27 (m, 1H, Ph-N(l)), 5.64 (d, 1H, 3J = 8.9 Hz, H-N-C(4)), 5.20 (dt, 1H, 3J= 8.9 Hz, 3J= 6.0 Hz, H-C(4)), 2.55 (d, 1H, 2J = 16.2 Hz, HaC(7)), 2.39 (d, 1H, 2J= 16.2 Hz, Hb-C(7)), 2.24 (s, 3H, H3C-C(3)), 2.23 (kv, 2H, 3J= 7.5 Hz, H-C(2’)),1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.45-7.40 (m, 4H, Ph-N (1)), 7.34-7.27 (m, 1H, Ph-N (1)), 5.64 ( d, 1H, 3 J = 8.9 Hz, HNC (4)), 5.20 (dt, 1H, 3 J = 8.9 Hz, 3 J = 6.0 Hz, HC (4)), 2.55 (d, 1H, 2 J = 16.2 Hz, HAC (7)), 2:39 (d, 1H, 2 J = 16.2 Hz, H-C (7)), 2.24 (s, 3H, H 3 CC (3)), 2.23 (sq, 2H, 3 J = 7.5 Hz, HC (2 ')),

l. 97 (dd, 1H, 2J= 13.2 Hz, 3J= 6.0 Hz, Ha-C(5)), 1.40 (dd, 1H, 2J= 13.2 Hz, 3J= 8.9 Hz, Hb-C(5)), 1.18 (t, 3H, 3J= 7.5 Hz, H-C(3’)), 1.07 (s, 3H, H3C-C(6)), 0.94 (s, 3H, H3C-C(6)).l. 97 (dd, 1H, 2 J = 13.2 Hz, 3 J = 6.0 Hz, Ha-C (5)), 1.40 (dd, 1H, 2 J = 13.2 Hz, 3 J = 8.9 Hz, Hb-C (5) ), 1.18 (t, 3H, 3 J = 7.5 Hz, HC (3 ')), 1.07 (s, 3H, H 3 C -C (6)), 0.94 (s, 3H, H 3 CC (6)).

nC-KMR (75 MHz, CDC13) δ (ppm): 173.1, 147.1, 140.1, 139.4, 129.2, 126.9, 123.2, 115.1, 44.1, 41.3, n C-NMR (75 MHz, CDC1 3) δ (ppm): 173.1, 147.1, 140.1, 139.4, 129.2, 126.9, 123.2, 115.1, 44.1, 41.3,

37.2, 32.7, 30.4, 29.9,25.8,12.4,10.0.37.2, 32.7, 30.4, 29.9,25.8,12.4,10.0.

Elementāranalīze: aprēķināts Ci9H25N3O0.2 H2O (333.70): C 68.34, H 8.30, N 12.58; atrasts C 68.56, H 8.13, N 12.59.Elementāranalīze: calculated Ci9H 2 3 O0.2 5N H 2 O (333.70): C 68.34, H 8.30, N 12:58; found C 68.56, H 8.13, N 12.59.

Piemērs 21.Example 21.

A-(3,6,6-Trimetil-l-fenil-4,5,6,7-tetrahidro-li/-indazol-4-il)-butiramīds l-Fenil-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (1,02 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina n-butilnitrilu (1.0 mL, 12 mmol, 3 ekv.). Aiztaisītā kolbā 5 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfījas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Trimethyl-1-phenyl-4,5,6,7-tetrahydro-1H-indazol-4-yl) -butyramide 1-Phenyl-4-hydroxy-3,6,6- To a solution of trimethyl-4,5,6,7-tetrahydroindazole (1.02 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (1.1 mL, 20 mmol, 5 mL) with magnetic stirring. eq.) then add n-butyl nitrile (1.0 mL, 12 mmol, 3 eq.). Continue stirring in a sealed flask for 5 hours at 60 ° C. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1.09 g, (83%).Yield: 1.09 g (83%).

Balta cieta viela, Rf = 0.12 (T/E = 2/1)White solid, Rf = 0.12 (T / E = 2/1)

k.p. 196 °C (EtOH/H2O 1/1)bp 196 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3305,2959,2370, 1638,1530, 1507,1383,1047.IS (KBr): 3305, 2959, 2370, 1638, 1530, 1507, 1383, 1047.

’H-KMR (300 MHz, CDC13) δ (ppm): 7.47-7.42 (m, 4H, Ph-N(l)), 7.35-7.29 (m, 1H, Ph-N(l)), 5.49 (d, 1H, 3J= 9.2 Hz, H-N-C(4)), 5.22 (ddd, 1H, 3J= 9.2 Hz, 3J= 8.7 Hz, 3J= 6.0 Hz, H-C(4)), 2.57 (d, 1H, 2J = 16.0 Hz, Ha-C(7)), 2.41 (d, 1H, 2J= 16.0 Hz, Hb-C(7)), 2.27 (s, 3H, H3C-C(3)), 2.19 (t, 2H, 3J= 7.9 Hz H-C(2’)), 2.01 (dd, 1H, 2J = 13.1 Hz, 3J= 6.0 Hz, Ha-C(5)), 1.72 (heks, 2H, 3J = 7.5 Hz, H-C(3’)), 1.23 (dd, 1H, 3J= 13.2 Hz, 3J= 8.7 Hz, Hb-C(5)), 1.09 (s, 3H, H3C-C(6)), 0.98 (t, 3H, 3J = 7.3 Hz, H-C(4’)), 0.96 (s, 3H, H3C-C(6)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.47-7.42 (m, 4H, Ph-N (1)), 7.35-7.29 (m, 1H, Ph-N (1)), 5.49 ( d, 1H, 3 J = 9.2 Hz, HNC (4)), 5.22 (ddd, 1H, 3 J = 9.2 Hz, 3 J = 8.7 Hz, 3 J = 6.0 Hz, HC (4)), 2.57 (d, 1H, 2 J = 16.0 Hz, Ha-C (7)), 2.41 (d, 1H, 2 J = 16.0 Hz, Hb-C (7)), 2.27 (s, 3H, H3 C-C (3)), 2.19 (t, 2H, 3 J = 7.9 Hz HC (2 ')), 2.01 (dd, 1H, 2 J = 13.1 Hz, 3 J = 6.0 Hz, Ha-C (5)), 1.72 (hex, 2H, 3 J = 7.5 Hz, HC (3 ')), 1.23 (dd, 1H, 3 J = 13.2 Hz, 3 J = 8.7 Hz, Hb-C (5)), 1.09 (s, 3H, H3 C-C (6 ), 0.98 (t, 3H, 3 J = 7.3 Hz, HC (4 ')), 0.96 (s, 3H, H3 C-C (6)).

13C-KMR (75 MHz, CDC13) δ (ppm): 172.1, 147.1, 140.2, 139.5, 129.1, 126.8, 123.3, 115.0, 44.1, 41.3, 13 C-NMR (75 MHz, CDC1 3) δ (ppm): 172.1, 147.1, 140.2, 139.5, 129.1, 126.8, 123.3, 115.0, 44.1, 41.3,

38.9, 37.2, 32.6, 30.3,25.9, 19.2,13.8, 12.4.38.9, 37.2, 32.6, 30.3,25.9, 19.2,13.8, 12.4.

Elementāranalīze: aprēķināts C2oH27N30«0.2 H2O (328.82): C 73.00, H 8.39, N 12.77; atrasts C 73.22, H 8.53, N 12.99.Elementāranalīze: calculated C 2 oH 2 3 7N 0 «0.2 H 2 O (328.82): C 73.00, H 8.39 N 12.77; found C 73.22, H 8.53, N 12.99.

Piemērs 22.Example 22.

7V-(3,6,6-Trimetil-l-fenil-4,5,6,7-tetrahidro-l/Z-indazoI-4-il)-2-fluor-benzamīds l-Fenil-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (1,02 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekv.), tad piepilina o-fluorbenzonitrilu (0,9 mL, 8 mmol, 2 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfījas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Trimethyl-1-phenyl-4,5,6,7-tetrahydro-1H-indazol-4-yl) -2-fluoro-benzamide 1-Phenyl-4-hydroxy-3 To a solution of 6,6-trimethyl-4,5,6,7-tetrahydroindazole (1.02 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (1.1 mL) with magnetic stirrer. , 20 mmol, 5 equiv), then add o-fluorobenzonitrile (0.9 mL, 8 mmol, 2 equiv). Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: L09 g, (71%).Yield: L09 g, (71%).

Balta cieta viela, Rf - 0.44 (T/E = 2/1) k.p. 159 °C (EtOH/H2O 1/1)White solid, Rf = 0.44 (T / E = 2/1) bp 159 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3247,2957, 2930, 2368, 1648, 1508, 1220,1103, 1069.IS (KBr): 3247, 2957, 2930, 2368, 1648, 1508, 1220, 1103, 1069.

’H-KMR (300 MHz, CDC13) δ (ppm): 8.16 (dd, 1H, 3J= Ί.Ί Hz, 4J= 1.7 Hz, H-C(Ar)), 7.51-7.43 (m, 5H, H-C(Ar)), 7.36-7.29 (m, 2H, H-C(Ar)), 7.12 (dd, 1H, 3J = 12.2 Hz,3J = 8.3 Hz, H-C(Ar)), 6.81 (d, 1H, 3J = 9.0 Hz, H-N-C(4)), 5.45 (ddd, 1H, 3J= 9.2 Hz, 3J= 8.3 Hz, 3J= 6.0 Hz, H-C(4)), 2.62 (d, 1H, 3J = 16.3 Hz, Ha-C(7)), 2.45 (d,lH, 2J= 16.3 Hz, Hb-C(7)), 2.29 (s, 3H, H3C-C(3)), 2.14 (dd, 1H, 2J= 13.2 Hz, 3J= 6.0 Hz, Ha-C(5)), 1.59 (dd, 1H, 3J= 13.2 Hz, 3J = 8.3 Hz, Hb-C(5)), 1.12 (s, 3H, H3C-C(6)), 1.02 (s, 3H, H3C-C(6)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 8.16 (dd, 1H, 3 J = Ί.Ί Hz, 4 J = 1.7 Hz, HC (Ar)), 7.51-7.43 (m, 5H, HC (Ar)), 7.36-7.29 (m, 2H, HC (Ar)), 7.12 (dd, 1H, 3 J = 12.2 Hz, 3 J = 8.3 Hz, HC (Ar)), 6.81 (d, 1H, 3 J = 9.0 Hz, HNC (4)), 5.45 (ddd, 1H, 3 J = 9.2 Hz, 3 J = 8.3 Hz, 3 J = 6.0 Hz, HC (4)), 2.62 (d, 1H, 3 J) = 16.3 Hz, Ha-C (7)), 2.45 (d, 1H, 2 J = 16.3 Hz, Hb-C (7)), 2.29 (s, 3H, H3 C-C (3)), 2.14 (dd, 1H, 2 J = 13.2 Hz, 3 J = 6.0 Hz, Ha-C (5)), 1.59 (dd, 1H, 3 J = 13.2 Hz, 3 J = 8.3 Hz, Hb-C (5)), 1.12 ( s, 3H, H 3 CC (6)), 1.02 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDC13) δ (ppm): 162.6 (d, Jc.f = 3 Hz), 160.5 (d, Jc.f = 247 Hz), 147.3, 140.1, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 162.6 (d, J c , f = 3 Hz), 160.5 (d, J c , f = 247 Hz), 147.3, 140.1,

139.6, 133.3 (d, 7C-f = 9 Hz), 132.1 (d, JC-t = 2 Hz), 129.1, 126.8, 124.9 (d, Jc.r = 3 Hz), 123.2, 121.0 (d, Jc-f = 12 Hz), 116.0 (d, JC-f = 25 Hz), 114.6,43.9,42.2,37.3,32.6, 30.1, 26.2,12.5.139.6, 133.3 (d, 7 C -f = 9 Hz), 132.1 (d, J C -t = 2 Hz), 129.1, 126.8, 124.9 (d, J c- r = 3 Hz), 123.2, 121.0 (d , J c -f = 12 Hz), 116.0 (d, J C -f = 25 Hz), 114.6,43.9,42.2,37.3,32.6, 30.1, 26.2,12.5.

Elementāranalīze: aprēķināts C23H24FN3 0*1/3 H2O (383.13): C 72.04, H 6.48, N 10.96; atrasts C 72.26, H 6.49, N 10.85.Elementāranalīze: calculated C23H24FN3 0 * 1/3 H 2 O (383.13): C 72.04, H 6.48 and N 10.96; Found: C 72.26, H 6.49, N 10.85.

Piemērs 23.Example 23.

A-(3,6,6-Trimetil-l-fenil-4,5,6,7-tetrahidro-l//-indazol-4-iI)-benzamīds l-Fenil-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (1,02 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,1 mL, 20 mmol, 5 ekviv.), tad piepilina benzonitrilu (1.2 mL, 12 mmol, 3 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Trimethyl-1-phenyl-4,5,6,7-tetrahydro-1 H -indazol-4-yl) -benzamide 1-Phenyl-4-hydroxy-3,6,6 Concentrated sulfuric acid (1.1 mL, 20 mmol) was added to a solution of -trimethyl-4,5,6,7-tetrahydroindazole (1.02 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) with magnetic stirring. 5 equiv.), Then add benzonitrile (1.2 mL, 12 mmol, 3 equiv.). Continue stirring in the stoppered flask at 60 ° C for four hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1,17 g, (80%).Yield: 1.17 g (80%).

Balta cieta viela, Rf = 0.26 (T/E = 2/1)White solid, Rf = 0.26 (T / E = 2/1)

k.p. 244 °C (EtOH/H2O 1/1)bp 244 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3299, 3057,2949, 2926, 1630, 1531,1507,1375, 1291, 1177, 1024,1045, 920.IS (KBr): 3299, 3057, 2949, 2926, 1630, 1531, 1507, 1375, 1291, 1177, 1024, 1045, 920.

’H-KMR (300 MHz, CDC13) δ (ppm): 7.79 (d, 3J= 7.3 Hz, Ph-C(l’)), 7.54-7.44 (m, 7H, Ph-N(l, 1’)), 7.38-7.32 (m, 1H, Ph-N(l)), 6.24 (d, 1H, 3J= 8.7 Hz, H-N-C(4)), 5.43 (dt, 1H, 3J= 6.2 Hz, 3J= 8.7 Hz, H-C(4)), 2.62 (d, 1H, 2J= 15.8 Hz, Ha-C(7)), 2.45 (d, 1H, 2J= 15.8 Hz, H„-C(7)), 2.29 (s, 3H, H3C-C(3)), 2.11 (dd, 1H, 2J= 13.1 Hz, 3J= 6.2 Hz, Ha-C(5)), 1.56 (dd, 1H, 2J= 13.1 Hz, 3J= 8.7 Hz, Hb-C(5)), 1.12 (s, 3H, H3C-C(6)), 1.01 (s, 3H, H3C-C(6)).1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.79 (d, 3 J = 7.3 Hz, Ph-C (1 ')), 7.54-7.44 (m, 7H, Ph-N (1.1) '), 7.38-7.32 (m, 1H, Ph-N (1)), 6.24 (d, 1H, 3 J = 8.7 Hz, HNC (4)), 5.43 (dt, 1H, 3 J = 6.2 Hz, 3 J = 8.7 Hz, HC (4)), 2.62 (d, 1H, 2 J = 15.8 Hz, Ha-C (7)), 2.45 (d, 1H, 2 J = 15.8 Hz, H 1 -C (7 ), 2.29 (s, 3H, H3 C-C (3)), 2.11 (dd, 1H, 2 J = 13.1 Hz, 3 J = 6.2 Hz, Ha-C (5)), 1.56 (dd, 1H, 2 J = 13.1 Hz, 3 J = 8.7 Hz, H-C (5)), 1.12 (s, 3H, H 3 CC (6)), 1:01 (s, 3H, H 3 CC (6)).

3C-KMR (75 MHz, CDC13) δ (ppm): 166.7, 147.2, 140.2, 139.4, 134.5, 131.5, 129.1, 128.7, 126.9, 13 C-NMR (75 MHz, CDCl 3 ) δ (ppm): 166.7, 147.2, 140.2, 139.4, 134.5, 131.5, 129.1, 128.7, 126.9,

126.8,123.2, 114.9, 44.0,42.0, 37.2, 32.7, 30.3,26.0,12.5126.8,123.2, 114.9, 44.0,42.0, 37.2, 32.7, 30.3,26.0,12.5

Elementāranalīze: aprēķināts C23H25N3O*l/3 H2O (365.14): C 75.59, H 7.08, N 11.50; atrasts C 75.85, H 6.96, N 11.54.Elementāranalīze: calculated C 23 H 5 N 3 O 2 * l / 3 H 2 O (365.14): C 75.59, H 7.08 and N 11:50; found C 75.85, H 6.96, N 11.54.

Piemērs 24.Example 24.

A-(3,6,6-Trimetil-l-fenil-4,5,6,7-tetrahidro-lH-indazol-4-il)-trihIoracetamīds l-Fenil-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (1,02 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (2,2 mL, 40 mmol, 10 ekv.), tad piepilina trihloracetonitrilu (8,0 mL, 80 mmol, 20 ekv.). Aiztaisītā kolbā 12 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Trimethyl-1-phenyl-4,5,6,7-tetrahydro-1H-indazol-4-yl) -trichloroacetamide 1-Phenyl-4-hydroxy-3,6,6-trimethyl To a solution of -4,5,6,7-tetrahydroindazole (1.02 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) was added concentrated sulfuric acid (2.2 mL, 40 mmol, 10 equiv) with a magnetic stirrer. ), then trichloroacetonitrile (8.0 mL, 80 mmol, 20 equiv) was added. Continue stirring in a closed flask at 60 ° C for 12 hours. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1.15 g, (72%).Yield: 1.15 g (72%).

Balta cieta viela, Rf = 0.26 (T/E = 2/1) kp. 146 °C (EtOH/HzO 1/1)White solid, R f = 0.26 (T / E = 2/1) bp. 146 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3267,2952, 1696,1507, 1078.IS (KBr): 3267, 2952, 1696, 1507, 1078.

’H-KMR (300 MHz, CDC13) δ (ppm): 7.48-7.42 (m, 4H, Ph-N(l)), 7.37-7.30 (m, 1H, Ph-N(l», 6.74 (d, 1H, 3J = 8.5 Hz, H-N-C(4)), 5.15 (ddd, 1H, 3J= 5.8 Hz,3./- 8.1 Hz, 3J = 8.5 Hz, H-C(4)), 2.61 (d, 1H, 2J = 16.2 Hz, Ha-C(7)), 2.45 (d, 1H, 16.2 Hz, Hb-C(7)), 2.29 (s, 3H, H3C-C(3)), 2.07 (dd, 1H, 2./- 13.21 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.48-7.42 (m, 4H, Ph-N (1)), 7.37-7.30 (m, 1H, Ph-N (1, 6.74) , 1H, 3 J = 8.5 Hz, HNC (4)), 5.15 (ddd, 1H, 3 J = 5.8 Hz, 3 ./- 8.1 Hz, 3 J = 8.5 Hz, HC (4)), 2.61 (d, 1 H, 2 J = 16.2 Hz, Ha-C (7)), 2.45 (d, 1H, 16.2 Hz, H b -C (7)), 2.29 (s, 3H, H 3 CC (3)), 2.07 ( dd, 1H, 2 ./- 13.2

Hz, 3J= 5.8 Hz, Ha-C(5)), 1.56 (dd, 1H, V- 13.1 Hz, 3J= 8.1 Hz, Hb-C(5)), 1.11 (s, 3H, H3C-C(6)), 1.00 (s, 3H, H3C-C(6)).Hz, 3 J = 5.8 Hz, H-C (5)), 1:56 (dd, 1H, V- 13.1 Hz, 3 J = 8.1 Hz, H-C (5)), 1.11 (s, 3H, H 3 CC (6)), 1.00 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CE>C13) δ (ppm): 161.0, 147.1, 140.4, 139.2, 129.2, 127.1, 123.3, 113.3, 92.7, 44.1, 13 C-NMR (75 MHz, CE> Cl 3 ) δ (ppm): 161.0, 147.1, 140.4, 139.2, 129.2, 127.1, 123.3, 113.3, 92.7, 44.1,

42.9, 37.0, 32.5, 29.8, 26.3,12.4.42.9, 37.0, 32.5, 29.8, 26.3, 12.4.

Elementāranalīze: aprēķināts CigH2oCl3N30 (399.07): C 53.95, H 5.03, N 10.49; atrasts C 53.93, H 4.93, N 10.45.Elemental Analysis: Calculated for C 18 H 20 OCl 3 N 3 O (399.07): C 53.95, H 5.03, N 10.49; found C 53.93, H 4.93, N 10.45.

Piemērs 25.Example 25.

7V-(3,6,6-Trimetil-l-fenil-4,5,6,7-tetrahidro-l//-indazol-4-iI)-hloracetamīds l-Fenil-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidroindazola (1,02 g, 4 mmol, 1 ekv.) šķīdumam ledus etiķskābē (4 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,7 mL, 32 mmol, 8 ekv.), tad piepilina hloracetonitrilu (1,0 mL, 16 mmol, 4 ekv.). Aiztaisītā kolbā 8 stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).N- (3,6,6-Trimethyl-1-phenyl-4,5,6,7-tetrahydro-1 H -indazol-4-yl) -chloroacetamide 1-Phenyl-4-hydroxy-3,6,6 Concentrated sulfuric acid (1.7 mL, 32 mmol) was added to a solution of -trimethyl-4,5,6,7-tetrahydroindazole (1.02 g, 4 mmol, 1 equiv) in glacial acetic acid (4 mL) with magnetic stirring. 8 eq.), Then chloroacetonitrile (1.0 mL, 16 mmol, 4 eq.) Was added. Continue stirring in a sealed flask for 8 hours at 60 ° C. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (55 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1,06 g, (80%).Yield: 1.06 g (80%).

Balta cieta viela, Rf = 0.60 (T/E = 2/1)White solid, Rf = 0.60 (T / E = 2/1)

k. p. 164 °C (EtOH/H2O 1/1)bp 164 ° C (EtOH / H 2 O 1/1)

IS (KBr): 3221, 3066, 2954, 1648, 1560, 1507, 1383, 1253, 1152, 1040.IS (KBr): 3221, 3066, 2954, 1648, 1560, 1507, 1383, 1253, 1152, 1040.

*H-KMR (300 MHz, CDC13) δ (ppm): 7.46-7.40 (m, 4H, Ph-N(l)), 7.34-7.27 (m, 1H, Ph-N(l)), 6.67 (d, 1H, 3J = 8.7 Hz, H-N-C(4)), 5.19 (dt, 1H, 3J= 6.0 Hz, 3J= 8.7 Hz, H-C(4)), 4.09 (s, 2H, H-C(2’), 2.58 (d, 1H, 2J= 16.2 Hz, Ha-C(7)), 2.41 (d, 1H, 2J= 16.2 Hz, Hb-C(7)), 2.24 (s, 3H, H3C-C(3)), 2.00 (dd, 1H, 2J= 13.0 Hz, 3J= 6.0 Hz, Ha-C(5)), 1.48 (dd, 1H, 2J= 13.1 Hz, 3J= 8.7 Hz, Hb-C(5)), 1.11 (s, 3H, H3C-C(6)),1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.46-7.40 (m, 4H, Ph-N (1)), 7.34-7.27 (m, 1H, Ph-N (1)), 6.67 ( d, 1H, 3 J = 8.7 Hz, HNC (4)), 5.19 (dt, 1H, 3 J = 6.0 Hz, 3 J = 8.7 Hz, HC (4)), 4.09 (s, 2H, HC (2 ') ), 2.58 (d, 1H, 2 J = 16.2 Hz, Ha-C (7)), 2.41 (d, 1H, 2 J = 16.2 Hz, Hb-C (7)), 2.24 (s, 3H, H 3 CC (3)), 2.00 (dd, 1H, 2 J = 13.0 Hz, 3 J = 6.0 Hz, Ha-C (5)), 1.48 (dd, 1H, 2 J = 13.1 Hz, 3 J = 8.7 Hz, H b -C (5)), 1.11 (s, 3H, H 3 CC (6)),

l. 00 (s, 3H, H3C-C(6)).l. 00 (s, 3H, H 3 CC (6)).

13C-KMR (75 MHz, CDCb) δ (ppm): 165.1, 147.0, 140.1, 139.4, 129.0, 126.8, 123.1, 113.9, 43.5, 42.5, 42.1,37.0, 32.5,30.1,25.9, 12.4. 13 C-NMR (75 MHz, CDCl 3) δ (ppm): 165.1, 147.0, 140.1, 139.4, 129.0, 126.8, 123.1, 113.9, 43.5, 42.5, 42.1.37.0, 32.5,30.1,25.9, 12.4.

Elementāranalīze: aprēķināts CigH22ClN3O*0.5 H2O (331.15): C 63.43, H 6.80, N 12.33; atrasts C 63.66, H 6.50, N 12.34.Elemental Analysis: Calculated for C 18 H 22 ClN 3 O * 0.5 H 2 O (331.15): C 63.43, H 6.80, N 12.33; Found: C 63.66, H 6.50, N 12.34.

Piemērs 26.Example 26.

6,6-DimetiI-l-feniI-6,7-dihidro-lH-indazols l-Fenil-4-hidroksi-6,6-dimetil-4,5,6,7-tetrahidro-l//-indazola (0,48 g, 2 mmol) šķīdumu acetilhloridā (2 ml) vāra 1,5 h un tad izlej ūdenī. Izkristalizējušos produktu filtrē un pārkristalizē no ethanola/ūdens maisījuma. Iznākums: 0,35 g (79%).6,6-Dimethyl-1-phenyl-6,7-dihydro-1H-indazole 1-Phenyl-4-hydroxy-6,6-dimethyl-4,5,6,7-tetrahydro-1 H -indazole (0 , 48 g, 2 mmol) in acetyl chloride (2 mL) is boiled for 1.5 h and then poured into water. The crystallized product is filtered and recrystallized from ethanol / water mixture. Yield: 0.35 g (79%).

k.p. 80-81 °C (EtOH/H2O 1/3) ‘H-KMR (300 MHz, CDC13) δ (ppm): 7.52 (s, 1H, H-C(3)), 7.49-7.45 (m, 4H, H-C(Ph)), 7.40-7.32 (m, 1H, H-C(Ph)), 6.32, 5.44 (2d, 2H, V= 9.6 Hz, H-C(4,5)), 2.79 (s, 2H, H-C(7)), 1.09 (s, 6H, H3C-C(6)).bp 80-81 ° C (EtOH / H 2 O 1/3) 1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 7.52 (s, 1H, HC (3)), 7.49-7.45 (m, 4H, HC (Ph)), 7.40-7.32 (m, 1H, HC (Ph)), 6.32, 5.44 (2d, 2H, V = 9.6 Hz, HC (4.5)), 2.79 (s, 2H, HC) (7)), 1.09 (s, 6H, H 3 CC (6)).

Elementāranalīze: aprēķināts C15H16N2 (224.30): C 80.32, H 7.19, N 12.49; atrasts C 80.11, H 7.32, NElemental Analysis: Calculated for C15H16N2 (224.30): C 80.32, H 7.19, N 12.49; found C 80.11, H 7.32, N

12.54.12.54.

Piemērs 27.Example 27.

3.6.6- Trimetil-l-feniI-6,7-dihidro-l//-indazols l-Fenil-4-hidroksi-3,6,6-trimetil-4,5,6,7-tetrahidro-l//-indazola (0,50 g, 2 mmol) šķīdumu acetilhloridā (2 mi) vāra 1,5 h un tad izlej ūdenī. Izkristalizējušos produktu filtrē un pārkristalizē no ethanola/ūdens maisījuma. Iznākums: 0,42 g (87%).3.6.6- Trimethyl-1-phenyl-6,7-dihydro-1 H -indazole 1-Phenyl-4-hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydro-1 H A solution of -indazole (0.50 g, 2 mmol) in acetyl chloride (2 mL) is boiled for 1.5 h and then poured into water. The crystallized product is filtered and recrystallized from ethanol / water. Yield: 0.42 g (87%).

k.p. 57-59 °C (EtOH/H2O 1/3) 'H-KMR (300 MHz, CDCb) δ (ppm): 7.48-7.41 (m, 4H, H-C(Ph)), 7.35-7.28 (m, 1H, H-C(Ph)), 6.28, 5.42 (2d, 2H, 37= 9.6 Hz, H-C(4,5)), 2.75 (s, 2H, H-C(7)), 2.31 (s, 3H, H3C-C(3)), 1.09 (s, 6H, H3CC(6)).mp 57-59 ° C (EtOH / H 2 O 1/3) 1 H-NMR (300 MHz, CDCl 3) δ (ppm): 7.48-7.41 (m, 4H, HC (Ph)), 7.35-7.28 (m , 1H, HC (Ph)), 6.28 and 5:42 (2d, 2H, 3 7 = 9.6 Hz, HC (4,5)), 2.75 (s, 2H, HC (7)), 2.31 (s, 3H, H 3 CC (3)), 1.09 (s, 6H, H 3 CC (6)).

13C-KMR (75 MHz, CDCI3) δ (ppm): 144.9, 139.5,138.0, 133.2, 129.1,126.7, 123.1, 116.9,115.9, 36.2, 13 C-NMR (75 MHz, CDCl 3) δ (ppm): 144.9, 139.5, 138.0, 133.2, 129.1, 126.7, 123.1, 116.9, 115.9, 36.2,

34.4.28.5.11.6.34.4.28.5.11.6.

Elementāranalīze: aprēķināts C16Hi8N2 (238.33): C 80.63, H 7.61, N 11.75; atrasts C 80.30, H 7.66, N 11.64.Elemental Analysis: Calculated for C 16 H 8 N 2 (238.33): C 80.63, H 7.61, N 11.75; Found: C 80.30, H 7.66, N 11.64.

Piemērs 28.Example 28.

3.6.6- Trimetil-l-piridīn-2-ii-6,7-diliidro-Lif-indazols3.6.6- Trimethyl-1-pyridin-2-yl-6,7-dihydro-Lif-indazole

4-Hidroksi-3,6,6-trimetil-l-(piridīn-2-il)-4,5,6,7-tetrahidro-li/-indazola (1.6 g, 6 mmol) šķīdumu acetilhloridā (6 ml) vāra 2 h un tad izlej ūdenī. Izkristalizējušos produktu filtrē un pārkristalizē no ethanola/ūdens maisījuma. Iznākums: 1.1 g (74%).A solution of 4-hydroxy-3,6,6-trimethyl-1- (pyridin-2-yl) -4,5,6,7-tetrahydro-1H-indazole (1.6 g, 6 mmol) in acetyl chloride (6 mL) is boiled 2 h and then pour into water. The crystallized product is filtered and recrystallized from ethanol / water. Yield: 1.1 g (74%).

k.p. 73-74 °C (EtOH) ’H-KMR (300 MHz, CDCb) δ (ppm): 8.40 (ddd, 1H, 7 = 4.9, 1.9, 0.8 Hz, H-C(Py)), 7.87 (dt, 1H, J =p.p. 73-74 ° C (EtOH) 1 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.40 (ddd, 1H, J = 4.9, 1.9, 0.8 Hz, HC (Py)), 7.87 (dt, 1H, J =

8.3, 0.8 Hz, H-C(Py)), 7.75 (ddd, 1H, 7=8.3, 7.3, 1.9 Hz, H-C(Py)), 7.10(ddd, 1H,7=7.3,4.9, 1.1, Hz, H-C(Py)), 6.22, 5.44 (2d, 2H, 37= 9.6 Hz, H-C(4,5)), 3.26 (s, 2H, H-C(7)), 2.30 (s, 3H, H3C-C(3)), 1.17 (s, 6H, H3C-C(6)).8.3, 0.8 Hz, HC (Py)), 7.75 (ddd, 1H, 7 = 8.3, 7.3, 1.9 Hz, HC (Py)), 7.10 (ddd, 1H, 7 = 7.3,4.9, 1.1, Hz, HC ( py)), 6.22 and 5:44 (2d, 2H, 3 7 = 9.6 Hz, HC (4,5)), 3.26 (s, 2H, HC (7)), 2.30 (s, 3H, H 3 CC (3) ), 1.17 (s, 6H, H 3 CC (6)).

13C-KMR (75 MHz, CDCb) δ (ppm): 153.2, 147.6, 145.9, 139.6, 138.1, 134.1, 120.4, 117.1, 116.1, 13 C-NMR (75 MHz, CDCl 3) δ (ppm): 153.2, 147.6, 145.9, 139.6, 138.1, 134.1, 120.4, 117.1, 116.1,

114.6, 37.6, 33.9, 28.8,11.7.114.6, 37.6, 33.9, 28.8,11.7.

Elementāranalīze: aprēķināts C15H17N5 (239.32): C 75.28, H 7.16, N 17.56; atrasts C 75.30, H 7.22, NElemental Analysis: Calculated for C 15 H 17 N 5 (239.32): C 75.28, H 7.16, N 17.56; Found: C 75.30, H 7.22, N

17.54.5:54 p.m.

Piemērs 29.Example 29.

A-(3,6,6-Trimetil-l-fenil-4,5,6,7-tetrahidro-17i-indazoI-4-il)-acetamīda sintēze no 3,6,6-trimetiI-lfenil-6,7-dihidro-l/F-indazolaSynthesis of A- (3,6,6-Trimethyl-1-phenyl-4,5,6,7-tetrahydro-17H-indazol-4-yl) -acetamide from 3,6,6-trimethyl-1-phenyl-6,7 -dihydro-1 H -indazole

3,6,6-Trimetil-l-fenil-6,7-dihidro-li/-indazola (1.19 g, 5 mmol, 1 ekv.) šķīdumam ledus etiķskābē (5 mL), maisot ar magnētisko maisītāju, pievieno koncentrētu sērskābi (1,4 mL, 25 mmol, 5 ekv.), tad piepilina acetonitrilu (1,25 mL, 25 mmol, 5 ekv.). Aiztaisītā kolbā tris stundas 60 °C temperatūra turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (70 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).To a solution of 3,6,6-trimethyl-1-phenyl-6,7-dihydro-1H-indazole (1.19 g, 5 mmol, 1 equiv.) In glacial acetic acid (5 mL) was added concentrated sulfuric acid (magnetic stirring). 1.4 mL, 25 mmol, 5 equiv), then add acetonitrile (1.25 mL, 25 mmol, 5 equiv). The flask is kept stirring for three hours at 60 ° C. Check the reaction solution on a silica gel thin-layer chromatography plate. The product is isolated by gradually pouring the reaction solution into 10% aqueous sodium hydroxide solution (70 mL) under cooling and stirring so that the temperature does not exceed 40 - 50 ° C and the pH is 10 - 11. (1: 1).

Iznākums: 1.16 g (78%)Yield: 1.16 g (78%)

Balta kristāliska viela Rf = 0.12 (T/E 1/2)White crystalline substance Rf = 0.12 (T / E 1/2)

k.p. 196 °C (EtOH/H2O 1/1)bp 196 ° C (EtOH / H 2 O 1/1)

Piemērs 30.Example 30.

7V-(6,(>-Dimetil-l-fenil-4,5,6,7-tetrahidro-l//-indazol-4-ir>-acetamīda sintēze trifluoretiķskābes šķīdumā l-Fenil-4-hidroksi-6,6-dimetil-4,5,6,7-tetrahidroindazola (0,96 g, 4 mmol, 1 ekv.) šķīdumam trifluoretiķskābē (5 mL) pievieno acetonitrilu (0,4 mL, 8 mmol, 2 ekv.). Aiztaisītā kolbā četras stundas 60 °C temperatūrā turpina maisīšanu. Reakcijas šķīdumu pārbauda uz silikagela plānslāņa hromatogrāfijas plāksnītes. Produktu izdala, pakāpeniski izlejot reakcijas šķīdumu 10% nātrija hidroksīda ūdens šķīdumā (55 mL) dzesējot un maisot tā, lai temperatūra nepārsniegtu 40 - 50 °C un pH būtu 10 - 11. Sākumā izdalījies sveķveida produkts pakāpeniski sacietē, to pārkristalizē no etanola un ūdens (1:1).Synthesis of N - (6, (- dimethyl-1-phenyl-4,5,6,7-tetrahydro-1 H -indazol-4-yl) -acetamide in trifluoroacetic acid solution 1-Phenyl-4-hydroxy-6,6 To a solution of -dimethyl-4,5,6,7-tetrahydroindazole (0.96 g, 4 mmol, 1 equiv) in trifluoroacetic acid (5 mL) was added acetonitrile (0.4 mL, 8 mmol, 2 equiv). Stirring is continued for 60 hours at 60 [deg.] C. The reaction solution is tested on a silica gel thin-layer chromatography plate. 10 - 11. Initially, the precipitated gum gradually solidified, recrystallized from ethanol and water (1: 1).

Iznākums: 1,0 g, (86%).Yield: 1.0 g (86%).

Balta cieta viela, Rf = 0,06 (T/E = 1/1)White solid, Rf = 0.06 (T / E = 1/1)

k.p. 198 °C (EtOH/H2O 1/1)bp 198 ° C (EtOH / H 2 O 1/1)

Piemērs 31.Example 31.

6,6-Dimetil-l-fenil-6,7-dihidro-LH-indazola sintēze šķidrā sēra dioksīdā l-Fenil-4-hidroksi-6,6-dimetil-4,5,6,7-tetrahidro-lH-indazolam (0,48 g, 2 mmol) spiedienreaktorā pievieno atdzesētu šķidru sēra dioksīdu (20 ml). Reaktoru noslēdz un reakcijas maisījumu iztur pie +90 °C 8 h. Sēra dioksīdu attvaicē pie 0 °C. Atlikumu kristalizē no etanola/ūdens maisījuma. Iznākums: 0,25 g (56%).Synthesis of 6,6-Dimethyl-1-phenyl-6,7-dihydro-LH-indazole in Liquid Sulfur Dioxide 1-Phenyl-4-hydroxy-6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazole (0.48 g, 2 mmol) was added cooled sulfur dioxide (20 mL) to the pressure reactor. The reactor is closed and the reaction mixture is kept at + 90 ° C for 8 h. The sulfur dioxide is evaporated at 0 ° C. The residue is crystallized from ethanol / water. Yield: 0.25 g (56%).

Claims (5)

PretenzijasClaims 1. Savienojumi ar vispārējo formulu I, kur aizvietotāji X, R1 un R2 atrodas visās iespējamās kombinācijās, un X ir N vai CH; R1 ietver, bet nav ierobežots ar: H, alkilaizvietotāju no Ci līdz C& R ietver, bet nav ierobežots ar: H, alkilaizvietotāju no Ci līdz C&, alkenilaizvietotāju no Cj līdz Cķ, -CHnClm grupu, kur n = 0-2 un m = 1-3, -CgHs, aizvietotu fenilciklu, kas satur vienu no sekojošām funkcionālām grupām jebkurā pozīcijā: -NO2, -F, -OCH3.Compounds of general formula I wherein X, R 1 and R 2 are present in all possible combinations and X is N or CH; R 1 include, but are not limited to: H, alkyl substituents of C to C & R include, but are not limited to: H, alkyl substituents of C to C &, alkenilaizvietotāju from Cj to Ck, CH n Cl m, wherein n = 0- 2 and m = 1-3, -CgH5, substituted phenyl ring containing one of the following functional groups at any position: -NO2, -F, -OCH3. 2. Savienojumu I sintēzes metode, no attiecīgajiem alkil-, halogēnalkil-, alkenilnitriliem vai aizvietotiem un neaizvietotiem arilnitriliem, vai HCN, vai TMSCN un 4-hidroksi-4,5,6,7tetrahidroindazoliem Π, kur X ir N vai CH; R1 ietver, bet nav ierobežots ar: H un alkilaizvietotāju no Cj līdz C6, skābā vidē, kuru veido, bet tā nav ierobežota ar: ledus etiķskābi, trifluoretiķskābi, konc. sērskābi, konc. fosforskābi, polifosforskābi, konc. perhlorskābi, p-toluolsulfoskabi, kamparsulfoskābi un to maisījumiem dažādās kombinācijās ar vai bez halogēnsaturošu organisko šķīdinātāju piedevas, kuras ietver, bet nav ierobežotas ar: dihlormetānu, hloroformu, 1,2dihloretānu.2. A process for the synthesis of compounds I from the corresponding alkyl, haloalkyl, alkenyl nitriles or substituted and unsubstituted aryl nitriles, or HCN or TMSCN and 4-hydroxy-4,5,6,7-tetrahydroindazoles Π, wherein X is N or CH; R 1 includes, but is not limited to: H and an alkyl substituent from C 1 to C 6 in an acidic medium consisting of, but not limited to: glacial acetic acid, trifluoroacetic acid, conc. sulfuric acid, conc. phosphoric acid, polyphosphoric acid, conc. perchloric acid, p-toluenesulfoscabic, camphorsulfonic acid and their mixtures, in various combinations with or without the addition of halogen-containing organic solvents, including but not limited to: dichloromethane, chloroform, 1,2-dichloroethane. 3. Savienojumu I sintēzes metode, no attiecīgajiem alkil-, halogēnalkil-, alkenilnitriliem vai aizvietotiem un neaizvietotiem arilnitriliem, vai HCN, vai TMSCN un 6,7-dihidroindazoliem III, kur X ir N yai CH; R1 ietver, bet nav ierobežots ar: H un alkilaizvietotāju no Q līdz C&, skābā vidē, kuru veido, bet tā nav ierobežota ar: ledus etiķskābi, trifluoretiķskābi, konc. sērskābi, konc. fosforskābi, polifosforskābi, konc. perhlorskābi, />-toluolsulfoskābi, kamparsulfoskābi un to maisījumiem dažādās kombinācijās ar vai bez halogensaturošu organisko šķīdinātāju piedevas, kuras ietver, bet nav ierobežotas ar: dihlormetānu, hloroformu, 1,2-dihloretānu.A process for the synthesis of compounds I from the corresponding alkyl, haloalkyl, alkenyl nitriles or substituted and unsubstituted aryl nitriles, or HCN or TMSCN and 6,7-dihydroindazoles III, wherein X is N yai CH; R 1 includes, but is not limited to: H and an alkyl substituent from Q to C &lt; 1 > in an acidic medium formed but not limited to: glacial acetic acid, trifluoroacetic acid, conc. sulfuric acid, conc. phosphoric acid, polyphosphoric acid, conc. perchloric acid, -> - toluenesulphonic acid, camphorsulphonic acid and their mixtures, in various combinations with or without halogenated organic solvent additives, including but not limited to: dichloromethane, chloroform, 1,2-dichloroethane. 4. Savienojumu HI sintēzes metode no savienojumiem Π skābā vidē, kuru veido, bet tā riav ierobežota ar: acetilhloridu, ledus etiķskābi, trifluoretiķskābi, konc. sērskābi, konc. fosforskābi, polifosforskābi, konc. peihlorskābi, konc. sālsskābi, p-toluolsulfosķābi, kamparsulfoskābi, šķidru sēra dioksīdu un to maisījumiem dažādās kombinācijās.4. Method for the synthesis of compounds HI from compounds Π in an acidic medium which is formed but limited to: acetyl chloride, glacial acetic acid, trifluoroacetic acid, conc. sulfuric acid, conc. phosphoric acid, polyphosphoric acid, conc. perchloric acid, conc. hydrochloric acid, p-toluenesulfonic acid, camphorsulfonic acid, liquid sulfur dioxide and mixtures thereof in various combinations. 5. Savienojumu I izmantošana tūā veidā vai maisījumā ar citām bioloģiski aktīvām vielām vai palīgvielām par pretsāpju (analgezējošiem) līdzekļiem.5. The use of compounds I as such or in admixture with other biologically active substances or excipients as analgesics.
LVP-11-167A 2011-12-07 2011-12-07 Sythesis of biologically active 4-acylamino-4,5,6,7-tetrahydroindazoles LV14476B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LVP-11-167A LV14476B (en) 2011-12-07 2011-12-07 Sythesis of biologically active 4-acylamino-4,5,6,7-tetrahydroindazoles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-11-167A LV14476B (en) 2011-12-07 2011-12-07 Sythesis of biologically active 4-acylamino-4,5,6,7-tetrahydroindazoles

Publications (2)

Publication Number Publication Date
LV14476A LV14476A (en) 2012-02-20
LV14476B true LV14476B (en) 2012-05-20

Family

ID=50152812

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-11-167A LV14476B (en) 2011-12-07 2011-12-07 Sythesis of biologically active 4-acylamino-4,5,6,7-tetrahydroindazoles

Country Status (1)

Country Link
LV (1) LV14476B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017077280A1 (en) * 2015-11-02 2017-05-11 Sonia Lain Tetrahydroindazoles and medical uses thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017077280A1 (en) * 2015-11-02 2017-05-11 Sonia Lain Tetrahydroindazoles and medical uses thereof
CN108349947A (en) * 2015-11-02 2018-07-31 S·莱恩 Tetrahydrochysene indazole and its medical usage
EP3974424A1 (en) * 2015-11-02 2022-03-30 Genase Therapeutics B.V. Tetrahydroindazoles and medical uses thereof

Also Published As

Publication number Publication date
LV14476A (en) 2012-02-20

Similar Documents

Publication Publication Date Title
CA2691987C (en) Antibacterial agents
CA2462692C (en) Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
US7517876B2 (en) Anti-infective agents
KR101441146B1 (en) Amine derivative having npy y5 receptor antagonist activity
RU2357958C2 (en) Imidazoline derivatives having cb1-antagonist activity
SE526022C2 (en) Crystalline base of citalopram
CA2492726A1 (en) 4-amino-substituted pyrimidine derivatives
CA2696429A1 (en) Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity
KR100490220B1 (en) Process for the preparation of 4-oxoimidazolinium salts
JP6301369B2 (en) Derivatives of homoserine lactone and their preparation and use
Obydennov et al. Bio-based triacetic acid lactone in the synthesis of azaheterocycles via a ring-opening transformation
LV14476B (en) Sythesis of biologically active 4-acylamino-4,5,6,7-tetrahydroindazoles
SU1169538A3 (en) Method of obtaining tricyclic compounds
KR20230023566A (en) one-pot synthesis Method of 1,3-Disubstitued indolizines
CN110483425B (en) Acyl thiourea compound, preparation method thereof and application of acyl thiourea compound in resisting influenza A virus
Gajera et al. Synthesis and antimicrobial activity of oxadiazole nucleus containing 2, 5-substituted 1, 3, 4-oxadiazole derivatives
CS244811B2 (en) Production method of new amides of substituted piperazin-1.yl-acetic acid
KR101630243B1 (en) Novel compounds, pharmaceutically acceptable salts thereof or optical isomer thereof, preparation method thereof and pharmaceutical composition for prevention or treatment of the viral diseases containing the same as an active ingredient
RU2785781C1 (en) Application of 4-(4-bromophenyl)-2-[2-(4-nitrobenzoyl)hydrazono]-4-oxobutanoic acid as an anti-inflammatory drug
Fujisaki et al. Preparation and chemical properties of 5-dialkylaminomethylhydantoins and 2-thio-analogues
Brzozowski et al. Syntheses of potassium 1, 1‐dioxopyrido [4, 3‐e]‐1, 4, 2‐dithiazine‐3‐thiolate and its application to the synthesis of novel sulfonamides with potential biological activity
WO2005028425A2 (en) Amidines and derivatives thereof and pharmaceutical compositions containing them
US20160130238A1 (en) New Process to make non nucleosidal reverse transcriptase inhibitors (NNRTI) for the treatment of HIV
Ahmad et al. Synthesis of new Schiff bases and 2, 3-disubstituted-1, 3-thiazolidin-4-one derivatives containing fluorene moiety
Bhuyan et al. tert-Butylhydroperoxide mediated radical cyanoalkylation/cyanoalkenylation of 2-anilino-1, 4-naphthoquinones with vinylarenes/arylalkynes and azobis (alkylcarbonitrile) s